{"id":16894,"date":"2024-03-19T14:43:03","date_gmt":"2024-03-19T05:43:03","guid":{"rendered":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/?page_id=16894"},"modified":"2026-01-08T16:18:52","modified_gmt":"2026-01-08T07:18:52","slug":"results","status":"publish","type":"page","link":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/department\/shinryoka\/sanfu\/results\/","title":{"rendered":"\u7523\u5a66\u4eba\u79d1 \u81e8\u5e8a\u7814\u7a76\u767a\u8868\u5b9f\u7e3e"},"content":{"rendered":"\n

\u5e73\u621028\u5e74\u5ea6\uff5e\u4ee4\u548c6\u5e74\u5ea6<\/h2>\n\n\n\n

\u4ee4\u548c6\u5e74\u5ea6<\/h3>\n\n\n\n

\u3010\u8ad6\u6587\u3011<\/p>\n\n\n\n

    \n
  1. Ikuo Hirano I\u3001Kanako Abe\u3001James Douglas Engelm\u3001Masayuki Yamamoto M\u3001Ritsuko Shimizu R. Atrain-dependent modifiers exacerbate familial leukemia caussed by GATA1-deficiency\u3001 Experimental Hematology & Oncology (23)1\u30012024<\/li>\n\n\n\n
  2. \u5b89\u90e8\u52a0\u5948\u5b50\u3001\u6c96\u660e\u5178\u3001\u9060\u85e4\u5468\u7950\u3001\u5c0f\u95a2\u4e45\u7f8e\u5b50\u3001\u89d2\u592e\u5f66\u3001\u718a\ufa11\u8aa0\u5e78\u3001\u52a0\u85e4\u656c\u3001\u9053\u4e0a\u5927\u96c4\u3001\u8d8a\u667a\u5bdb\u5e78\u3001\u5f53\u9662\u306b\u304a\u3051\u308b\u8981\u652f\u63f4\u598a\u7523\u5a66\u306e\u80cc\u666f\u3068\u652f\u63f4\u306e\u73fe\u72b6\u5831\u544a.\u8328\u57ce\u770c\u7acb\u75c5\u9662\u533b\u5b66\u96d1\u8a8c2024<\/li>\n\n\n\n
  3. \u718a\ufa11\u8aa0\u5e78\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u9ad8\u968e\u6c99\u82f1\u7f8e\u3001\u4f0a\u6771\u6176\u5f66\u3001\u6771\u798f\u7965\u3001\u52a0\u85e4\u656c\u3001\u9053\u4e0a\u5927\u96c4\u3001\u8d8a\u667a\u5bdb\u5e78\u3001\u6c96\u660e\u5178\u3001\u30e1\u30bd\u30c8\u30ec\u30ad\u30bb\u30fc\u30c8\u306e\u7d4c\u8179\u7684\u8907\u6570\u56de\u5c40\u6240\u6ce8\u5165\u304c\u594f\u529f\u3057\u305f\u5375\u7ba1\u9593\u8cea\u90e8\u598a\u5a20\u306e2\u4f8b.\u8328\u57ce\u770c\u7acb\u75c5\u9662\u533b\u5b66\u96d1\u8a8c2024<\/li>\n<\/ol>\n\n\n\n

    \u3010\u5b66\u4f1a\u767a\u8868\u3011<\/p>\n\n\n\n

      \n
    1. \u89d2\u592e\u5f66\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u9060\u85e4\u5468\u7950\u3001\u53e4\u95a2\u4e45\u7f8e\u5b50\u3001\u52a0\u85e4\u656c\u3001\u9053\u4e0a\u5927\u96c4\u3001\u8d8a\u667a\u5bdb\u5e78\u3001\u6c96\u660e\u5178\u3001\u30ec\u30dc\u30ce\u30eb\u30b2\u30b9\u30c8\u30ec\u30eb\u5f90\u653e\u578bIUS(LNG-IUS)\u88c5\u7740\u5f8c\u306b\u6025\u901f\u306b\u5b50\u5bae\u7b4b\u816b\u304c\u5897\u5927\u3057\u305f\u4e00\u4f8b.\u7b2c147\u56de\u95a2\u6771\u9023\u5408\u7523\u79d1\u5a66\u4eba\u79d1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a\u30012024.7(\u6771\u4eac)2024.7.6.15-16<\/li>\n\n\n\n
    2. \u5b89\u90e8\u52a0\u5948\u5b50\u3001\u9f4b\u6d0b\u5b50\u3001\u89d2\u592e\u5f66\u3001\u9808\u85e4\u9ebb\u5b9f\u3001\u52a0\u85e4\u656c\u3001\u9053\u4e0a\u5927\u96c4\u3001\u8d8a\u667a\u5bdb\u5e78\u3001\u4f50\u85e4\u664b\u723e\u3001\u6c96\u660e\u5178.\u8eab\u4f53\u75c7\u72b6\u3067\u7d39\u4ecb\u521d\u8a3a\u3068\u306a\u3063\u305f\u7523\u79d1\u5916\u6765\u3067\u598a\u5a20\u3046\u3064\u3092\u7591\u3044\u30c1\u30fc\u30e0\u533b\u7642\u306b\u3088\u308a\u7cbe\u795e\u79d1\u306e\u65e9\u671f\u4ecb\u5165\u304c\u3067\u304d\u305f\u91cd\u75c7\u598a\u5a20\u3046\u3064\u306e2\u75c7\u4f8b.\u7b2c62\u56de\u5168\u56fd\u81ea\u6cbb\u4f53\u75c5\u9662\u5b66\u4f1a\u30012024.11\uff08\u65b0\u6f5f\uff092024.11.1-2<\/li>\n\n\n\n
    3. \u5409\u7530\u4e43\u5b50\u3001\u5609\u5cf6\u5df4\u3001\u9752\u7825\u831c\u3001\u8352\u4e95\u5343\u9db4\u5b50\u3001\u9f4b\u6d0b\u5b50\u3001\u79cb\u5c71\u9806\u5b50\u3001\u6c96\u660e\u5178.\u300c\u81ea\u5b85\u3067\u306e\u770b\u53d6\u308a\u3092\u5e0c\u671b\u3057\u305f\u7d42\u672b\u671f\u304c\u3093\u60a3\u8005\u306b\u304a\u3051\u308b\u9000\u9662\u652f\u63f4\u300d\uff5e\u5730\u57df\u533b\u7642\u3078\u3064\u306a\u3050\u305f\u3081\u306e\u591a\u8077\u7a2e\u9023\u643a\u306e\u53d6\u308a\u7d44\u307f\uff5e,\u7b2c62\u56de\u5168\u56fd\u81ea\u6cbb\u4f53\u75c5\u9662\u5b66\u4f1a\u30012024.11\uff08\u65b0\u6f5f\uff092024.11.1-2<\/li>\n\n\n\n
    4. \u7af9\u5185\u4f73\u7e54\u3001\u8d8a\u667a\u5bdb\u5e78\u3001\u5c0f\u6cbc\u572d\u7950\u3001\u6728\u6751\u82f1\u4eba\u3001\u89d2\u592e\u5f66\u3001\u9808\u85e4\u9ebb\u5b9f\u3001\u52a0\u85e4\u656c\u3001\u9053\u4e0a\u5927\u96c4\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u6c96\u660e\u5178.\u5b50\u5bae\u4f53\u764c\u9aa8\u8ee2\u79fb\u3068\u306e\u9451\u5225\u306b\u82e6\u616e\u3057\u305f\u591a\u767a\u6027\u9aa8\u9ac4\u816b\u306e1\u4f8b.\u7b2c19\u56de\u8328\u57ce\u7523\u79d1\u5a66\u4eba\u79d1\u5b66\u4f1a\u4f8b\u4f1a\u30012024.11\uff08\u6c34\u6238\uff092024.11.30<\/li>\n\n\n\n
    5. \u5c0f\u6cbc\u572d\u7950\u3001\u8d8a\u667a\u5bdb\u5e78\u3001\u6728\u6751\u82f1\u4eba\u3001\u89d2\u592e\u5f66\u3001\u7af9\u5185\u4f73\u7e54\u3001\u9808\u85e4\u9ebb\u5b9f\u3001\u52a0\u85e4\u656c\u3001\u9053\u4e0a\u5927\u96c4\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u6c96\u660e\u5178.TC\u7642\u6cd5\u3067\u90e8\u5206\u594f\u529f\u304c\u5f97\u3089\u308c\u305f\u03b1-Fetoprotein\uff08AFP\uff09\u7523\u751f\u8179\u819c\u764c\u306e1\u4f8b.\u7b2c19\u56de\u8328\u57ce\u7523\u79d1\u5a66\u4eba\u79d1\u5b66\u4f1a\u4f8b\u4f1a\u30012024.11\uff08\u6c34\u6238\uff092024.11.30<\/li>\n\n\n\n
    6. \u5609\u5cf6\u5df4\u3001\u90e1\u53f8\u601c\u7f8e\u3001\u5185\u91ce\u667a\u5b50\u3001\u9f4b\u6d0b\u5b50\u3001\u79cb\u5c71\u9806\u5b50\u3001\u6c96\u660e\u5178.\u30c0\u30a6\u30f3\u75c7\u5150\u544a\u77e5\u5f8c\u306e\u6bcd\u5150\u306e\u611b\u7740\u5f62\u6210\u306b\u3064\u306a\u304c\u308b\u52a9\u7523\u5e2b\u306e\u95a2\u308f\u308a.\u7b2c\uff14\uff13\u56de\u8328\u57ce\u770c\u6bcd\u6027\u885b\u751f\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a\u30012024.12\uff08\u65e5\u7acb\uff092024.12.7<\/li>\n<\/ol>\n\n\n\n

      \u4ee4\u548c5\u5e74\u5ea6<\/h3>\n\n\n\n

      \u3010\u8ad6\u6587\u3011<\/p>\n\n\n\n

        \n
      1. \u7530\u6751\u5927\u6a39\u3001\u9ad8\u91ce\u514b\u5df1\u3001\u5b89\u90e8\u4f73\u5948\u5b50\u3001\u5152\u7389\u7406\u3001\u9053\u4e0a\u5927\u96c4\u3001\u7389\u4e95\u306f\u308b\u306a\u3001\u9ad8\u5c3e\u822a\u3001\u539f\u7d62\u9999\u3001\u6a0b\u53e3\u5927\u6a39\u3001\u6c96\u660e\u5178.\uff1a\u5f53\u9662\u3067\u7d4c\u9a13\u3057\u305f\u6210\u719f\u56a2\u80de\u6027\u5947\u5f62\u9152\u306e\u60aa\u6027\u8ee2\u53166\u4f8b\u306e\u691c\u8a0e\u3001 \u8328\u57ce\u770c\u7acb\u75c5\u9662\u533b\u5b66\u96d1\u8a8c(39) 1 :\u300013-19\u30012023\uff083\u6708\uff09<\/li>\n\n\n\n
      2. \u5742\u5834\u5927\u8f14\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u9053\u4e0a\u5927\u96c4\u3001\u9ad8\u968e\u6c99\u82f1\u7f8e\u3001\u4e94\u5473\u9999\u7e54\u3001\u9ad8\u5c3e\u822a\u3001\u52a0\u85e4\u656c\u3001\u9ad8\u91ce\u514b\u5df1\u3001\u6c96\u660e\u5178. \u598a\u5a20\u521d\u671f\u306b\u304a\u3044\u3066\u60aa\u6027\u5375\u5de3\u816b\u760d\u3092\u7591\u3063\u305f\u5909\u5247\u767a\u751f\u306e\u9ec4\u4f53\u5316\u904e\u5270\u53cd\u5fdc(Hyperreactio Luteinalis)\u306e\u4e00\u4f8b\u3001 \u95a2\u6771\u9023\u5408\u7523\u79d1\u5a66\u4eba\u79d1\u5b66\u4f1a\u8a8c (60) 4: 551-558\u30012023(11\u6708)<\/li>\n<\/ol>\n\n\n\n

        \u4ee4\u548c4\u5e74\u5ea6<\/h3>\n\n\n\n

        \u3010\u8ad6\u6587\u3011<\/strong><\/p>\n\n\n\n

          \n
        1. Dai Akine, Teppei Sasahara, Ayako Koido, Kaori Abe, Kanako Abe, Akinori Oki, Noriyuki Takeyasu, Ikuta Hashimoto. Case of a pregnant woman with probable prolonged SARS-CoV-2 viral shedding 221 days after diagnosis. Journal of Infection and Chemotherapy.28(7): 998-1000, 2022<\/li>\n\n\n\n
        2. \u4e94\u5473\u9999\u7e54\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u67ff\u6cbc\u5dba\u65bc\u5948\u3001\u5742\u5834\u5927\u8f14\u3001\u9ad8\u5c3e \u822a\u3001\u52a0\u85e4 \u656c\u3001\u9053\u4e0a\u5927\u96c4\u3001\u9ad8\u91ce\u514b\u5df1\u3001\u6c96 \u660e\u5178. \u7523\u8925\u6a5f\u306e\u598a\u5a20\u9ad8\u8840\u5727\u75c7\u5019\u7fa4\u306e\u305b\u3044\u3060\u3067\u539f\u767a\u6027\u30a2\u30eb\u30c9\u30b9\u30c6\u30ed\u30f3\u75c7\u3068\u8a3a\u65ad\u3055\u308c\u305f\u4e00\u4f8b. \u95a2\u6771\u7523\u5a66\u8a8c (59): 475-480, 2022<\/li>\n\n\n\n
        3. \u5b89\u90e8\u52a0\u5948\u5b50\u3001\u9752\u5c71\u4e00\u7d00\u3001\u9f4b \u6d0b\u5b50\u3001\u9ad8\u968e\u6c99\u82f1\u7f8e\u3001\u5742\u5834\u5927\u8f14\u3001\u4e94\u5473\u9999\u7e54\u3001\u6771 \u798f\u7965\u3001\u52a0\u85e4 \u656c\u3001\u9053\u4e0a\u5927\u96c4\u3001\u8d8a\u667a\u5bdb\u5e78\u3001\u4f50\u85e4\u664b\u723e\u3001\u6c96 \u660e\u5178. \u300c\u6388\u4e73\u3068\u304a\u304f\u3059\u308a\u5916\u6765\u300d\u8a2d\u7acb\u5f8c\u306e\u7cbe\u795e\u75be\u60a3\u5408\u4f75\u598a\u5a66\u306e\u6bcd\u4e73\u80b2\u5150\u306e\u73fe\u72b6\u5831\u544a. \u8328\u57ce\u770c\u7acb\u75c5\u9662\u533b\u5b66\u96d1\u8a8c(39) 1 :\u300017-22, 20\uff122\uff0810\u6708\uff09<\/li>\n<\/ol>\n\n\n\n

          \u3010\u5b66\u4f1a\u5831\u544a\u3011<\/strong><\/p>\n\n\n\n

            \n
          1. \u9ad8\u91ce\u514b\u5df1\uff0c\u9053\u4e0a\u5927\u96c4\uff0c\u9ad8\u5c3e \u822a\uff0c\u52a0\u85e4 \u656c\uff0c\u67ff\u6cbc\u9e97\u65bc\u5948\u3001\u4e94\u5473\u9999\u7e54\uff0c\u5742\u5834\u5927\u8f14\uff0c\u5b89\u90e8\u52a0\u5948\u5b50\uff0c\u6c96 \u660e\u5178. \u30ed\u30dc\u30c3\u30c8\u624b\u8853\u306b\u304a\u3051\u308b\u958b\u8179\u8853\u65e2\u5f80\u306e\u3042\u308b\u75c7\u4f8b\u306b\u5bfe\u3059\u308b\u30aa\u30d7\u30c6\u30a3\u30ab\u30eb\u6cd5\u306e\u6709\u7528\u6027\uff5e\u958b\u8179\u65e2\u5f80\u306e\u80a5\u6e80\u75c7\u4f8b\u306b\u5bfe\u3059\u308b\u30dd\u30fc\u30c8\u8a2d\u7f6e\u306e\u5931\u6557\u3092\u7d4c\u9a13\u3057\u3066\uff5e. \u7b2c10\u56de\u65e5\u672c\u5a66\u4eba\u79d1\u30ed\u30dc\u30c3\u30c8\u624b\u8853\u5b66\u4f1a(\u9759\u5ca1\uff092022.1.29-30<\/li>\n\n\n\n
          2. \u67f3\u5ddd \u5fb9\u3001\u6c96 \u660e\u5178\u3001\u6301\u7530\u96c4\u5b50\u3001\u6c34\u91ce\u5b5d\u5b50\u3001\u677e\u91d1\u5948\u7dd2\u3001\u5e38\u4e95\u7531\u4f73\u5229\u3001\u5927\u6728\u5b8f\u4ecb\u3001\u91ce\u53e3\u7be4\u90ce\u3001\u8429\u539f\u654f\u4e4b\u3001\u5185\u7530\u6587\u5f66\u3001\u83c5\u91ce\u76f4\u7f8e\u3001\u5c71\u7e23\u61b2\u53f8\u3001\u5c0f\u5cf6 \u5bdb\u3001\u6b66\u5ddd\u5bdb\u6a39. \u8328\u57ce\u770c\u7acb\u4e2d\u592e\u75c5\u9662\u306b\u304a\u3051\u308b\u5468\u8853\u671f\u7b49\u53e3\u8154\u6a5f\u80fd\u7ba1\u7406\u306e\u6709\u52b9\u6027\u306e\u8a55\u4fa1\u30fc\u5a66\u4eba\u79d1\u60aa\u6027\u816b\u760d\u60a3\u8005\u306b\u304a\u3051\u308b\u6709\u52b9\u6027\u306b\u3064\u3044\u3066. \u7b2c30\u56de\u8328\u57ce\u770c\u6b6f\u79d1\u533b\u5b66\u4f1a(\u6c34\u6238\uff09\u30002022.3.13.<\/li>\n\n\n\n
          3. <\/strong>\u77f3\u5802\u4f73\u4e16,\u68ee\u5343\u5b50,\u9f4b\u85e4\u8aa0,\u9ad8\u91ce\u514b\u5df1. \u6570\u5e74\u5148\u306e\u30ea\u30b9\u30af\u4f4e\u6e1b\u5375\u7ba1\u5375\u5de3\u6458\u51fa\u8853\u3082\u898b\u636e\u3048\u305f\u5f53\u9662\u306e\u907a\u4f1d\u30ab\u30a6\u30f3\u30bb\u30ea\u30f3\u30b0\u306b\u3064\u3044\u3066\u306e\u691c\u8a0e. \u7b2c46\u56de\u65e5\u672c\u907a\u4f1d\u30ab\u30a6\u30f3\u30bb\u30ea\u30f3\u30b0\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff08\u6771\u4eac\uff09\u30002022.7.1-3\u3000<\/strong><\/li>\n\n\n\n
          4. \u4e94\u5473\u9999\u7e54\u3001\u9053\u4e0a\u5927\u96c4\u3001\u5742\u5834\u5927\u8f14\u3001\u9ad8\u5c3e \u822a\u3001\u52a0\u85e4 \u656c\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u9ad8\u91ce\u514b\u5df1\u3001\u77e2\u90e8\u6587\u9855\u3001\u6c96 \u660e\u5178. \u30da\u30b0\u30d5\u30a3\u30eb\u30b0\u30e9\u30b9\u30c1\u30e0\u304c\u539f\u56e0\u3068\u8003\u3048\u3089\u308c\u308b\u52d5\u8108\u708e\u6027\u865a\u8840\u6027\u8996\u795e\u7d4c\u75c7\u3067\u5931\u660e\u3057\u305f\u518d\u767a\u5375\u5de3\u764c\u306e\u4e00\u4f8b. \u7b2c64\u56de\u65e5\u672c\u5a66\u4eba\u79d1\u816b\u760d\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a\uff08\u4e45\u7559\u7c73\uff092022.7.14-16<\/li>\n\n\n\n
          5. <\/strong>\u5b89\u90e8 \u52a0\u5948\u5b501, \u9f4b \u6d0b\u5b502, \u9ad8\u968e \u6c99\u82f1\u7f8e1, \u4e94\u5473 \u9999\u7e541, \u6771 \u798f\u6d0b1, \u52a0\u85e4 \u656c1, \u9053\u4e0a \u5927\u96c41, \u8d8a\u667a \u5bdb\u5e781, \u6c96 \u660e\u5178. \u5f53\u9662\u306b\u304a\u3051\u308b\u8981\u652f\u63f4\u598a\u7523\u5a66\u306e\u80cc\u666f\u3068\u591a\u8077\u7a2e\u9023\u643a\u306b\u3088\u308b\u652f\u63f4\u306e\u73fe\u72b6\u5831\u544a. \u7b2c\uff16\uff10\u56de\u5168\u56fd\u81ea\u6cbb\u4f53\u75c5\u9662\u5b66\u4f1a\uff08\u90a3\u8987\uff09\u30002022.11.10-11<\/strong><\/li>\n\n\n\n
          6. \u9ad9\u968e\u6c99\u82f1\u7f8e\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u79cb\u6839 \u5927\u3001\u4e94\u5473\u9999\u7e54\u3001\u6771 \u798f\u7965\u3001\u9ad8\u5c3e \u822a\u3001\u52a0\u85e4 \u656c\u3001\u9053\u4e0a\u5927\u96c4\u3001\u8d8a\u667a\u5bdb\u5e78\u3001\u6c96 \u660e\u5178. \u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\uff08COVID-19\uff09\u611f\u67d3\u5f8c\u3001\u9577\u671f\u306e\u30a6\u30a4\u30eb\u30b9\u6392\u6cc4\u9077\u5ef6\u3092\u8a8d\u3081\u305f\u598a\u5a66\u306e\u4e8c\u4f8b.\u7b2c\uff11\uff14\uff14\u56de\u95a2\u6771\u9023\u5408\u7523\u79d1\u5a66\u4eba\u79d1\u5b66\u4f1a\u7dcf\u4f1a\uff08\u7532\u5e9c\uff092022.10.15-16.<\/li>\n\n\n\n
          7. \u718a\u5d0e\u8aa0\u5e78\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u9ad8\u968e\u6c99\u82f1\u7f8e\u3001\u4f0a\u6771\u6176\u5f66\u3001\u6771 \u798f\u7965\u3001\u52a0\u85e4 \u656c\u3001\u9053\u4e0a\u5927\u96c4\u3001\u8d8a\u667a\u5bdb\u5e78\u3001\u6c96 \u660e\u5178. \u30e1\u30bd\u30c8\u30ec\u30ad\u30bb\u30fc\u30c8\u5c40\u6240\u8907\u6570\u56de\u6295\u4e0e\u304c\u594f\u529f\u3057\u305f\u5375\u7ba1\u9593\u8cea\u90e8\u598a\u5a20\u306e\uff12\u4f8b. \u7b2c192\u56de\u8328\u57ce\u7523\u79d1\u5a66\u4eba\u79d1\u5b66\u4f1a\u4f8b\u4f1a\uff08\u6c34\u6238\uff092022.11.26<\/li>\n<\/ol>\n\n\n\n

            \u4ee4\u548c3\u5e74\u5ea6<\/h3>\n\n\n\n

            \u3010\u8ad6\u6587\u3011<\/p>\n\n\n\n

              \n
            1. Yosuke Konno, Hiroshi Asano, Ayumi Shikama, Daisuke Aoki, Michihiro Tanikawa, Akinori Oki, Koji Horie, Akira Mitsuhashi, Akira Kikuchi, Hideki Tokunaga,  Yasuhisa Terao, Toyomi Satoh, Kimio Ushijima, Mitsuya Ishikawa, Nobuo Yaegashi, Hidemichi Watari. Lymphadenectomy issues in endometrial cancer. JOURNAL OF GYNECOLOGIC ONCOLOGY\/32(2), 2021-03<\/li>\n\n\n\n
            2. \u4e45\u4fdd\u8c37\u8a17\u4e5f\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u539f\u3000\u7d62\u9999\u3001\u9ad8\u5c3e\u3000\u822a\u3001\u7389\u4e95\u306f\u308b\u306a\u3001\u5150\u7389\u3000\u7406\u3001\u9053\u4e0a\u5927\u96c4\u3001\u9ad8\u91ce\u514b\u5df1\u3001\u6c96  \u660e\u5178. \u514d\u75ab\u30c1\u30a7\u30c3\u30af\u30dd\u30a4\u30f3\u30c8\u963b\u5bb3\u85ac\u306b\u3088\u308a\u7121\u5897\u60aa\u751f\u5b58\u304c\u5f97\u3089\u308c\u3066\u3044\u308b\u8ee2\u79fb\u6027\u518d\u767a\u5916\u9670\u60aa\u6027\u9ed2\u8272\u816b\u306e\u4e00\u4f8b. \u95a2\u6771\u7523\u5a66\u8a8c 59: 11-16, 2022\uff081\u6708\uff09<\/li>\n<\/ol>\n\n\n\n

              \u3010\u5b66\u4f1a\u5831\u544a\u3011<\/p>\n\n\n\n

                \n
              1. \u9ad8\u5c3e \u822a\uff64\u9ad8\u91ce\u514b\u5df1\u3001\u4e45\u4fdd\u8c37\u8a17\u4e5f\u3001\u539f \u7d62\u9999\u3001\u7389\u4e95\u306f\u308b\u306a\u3001\u9053\u4e0a\u5927\u96c4\u3001\u5152\u7389 \u7406\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u6c96 \u660e\u5178\u3001\u5409\u5ddd\u88d5\u4e4b. \u5f53\u9662\u306b\u304a\u3051\u308b\u65e9\u671f\u5b50\u5bae\u4f53\u764c\u306b\u5bfe\u3059\u308b\u93e1\u8996\u4e0b\u624b\u8853\u306e\u6cbb\u7642\u6210\u7e3e. \u7b2c62\u56de\u65e5\u672c\u5a66\u4eba\u79d1\u816b\u760d\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a(\u4ed9\u53f0\/WEB\uff092021. 1.29-30<\/li>\n\n\n\n
              2. \u9053\u4e0a\u5927\u96c4\u3001\u77f3\u9ed2\u614e\u543e\u3001\u4e45\u4fdd\u8c37\u8a17\u4e5f\u3001\u539f \u7d62\u9999\u3001\u9ad8\u5c3e \u822a\uff64\u7389\u4e95\u306f\u308b\u306a\u3001\u5152\u7389 \u7406\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u9ad8\u91ce\u514b\u5df1\u3001\u77f3\u5802\u4f73\u4e16\u3001\u9f4b\u85e4 \u8aa0\u3001\u6c96 \u660e\u5178. Pembrolizumab\u306b\u3088\u308a\u90e8\u5206\u594f\u529f\u304c\u5f97\u3089\u308c\u3066\u3044\u308b\uff64\u96e3\u6cbb\u6027\u5b50\u5bae\u4f53\u764c\u306e\u4e00\u4f8b. \u7b2c62\u56de\u65e5\u672c\u5a66\u4eba\u79d1\u816b\u760d\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a(\u4ed9\u53f0\/WEB\uff092021. 1.29-30<\/li>\n\n\n\n
              3. \u9ad8\u5c3e \u822a\uff64\u9ad8\u91ce\u514b\u5df1\u3001\u4e45\u4fdd\u8c37\u8a17\u4e5f\u3001\u539f \u7d62\u9999\u3001\u7389\u4e95\u306f\u308b\u306a\u3001\u9053\u4e0a\u5927\u96c4\u3001\u5152\u7389 \u7406\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u6c96 \u660e\u5178\u3001\u5409\u5ddd\u88d5\u4e4b. \u5f53\u9662\u306b\u304a\u3051\u308b\u5375\u5de3\u764c\u306b\u5bfe\u3059\u308bOlaparib\u6295\u4e0e\u75c7\u4f8b\u306e\u691c\u8a0e. \u7b2c73\u56de\u65e5\u672c\u7523\u79d1\u5a66\u4eba\u79d1\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a\uff08WEB\u958b\u50ac\uff092020.4.<\/li>\n\n\n\n
              4. (\u67ff\u6cbc\u73b2\u65bc\u5948)\u3001\u4e94\u5473\u9999\u7e54\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u7530\u6751\u5927\u6a39\u3001\u6a0b\u53e3\u5927\u6a39\u3001\u9ad8\u5c3e \u822a\uff64\u52a0\u85e4 \u656c\u3001\u9053\u4e0a\u5927\u96c4\u3001\u9ad8\u91ce\u514b\u5df1\uff64\u6c96 \u660e\u5178. \u598a\u5a20\u9ad8\u8840\u5727\u75c7\u5019\u7fa4\u306e\u5206\u5a29\u5f8c\u7cbe\u67fb\u306b\u3088\u308a\u539f\u767a\u6027\u30a2\u30eb\u30c9\u30b9\u30c6\u30ed\u30f3\u75c7\u3068\u8a3a\u65ad\u3055\u308c\u305f\u4e00\u4f8b. \u7b2c140\u56de\u95a2\u6771\u9023\u5408\u7523\u5a66\u4eba\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a(WEB\uff092021.7\u3000<\/li>\n\n\n\n
              5. \u77f3\u5802\u4f73\u4e16\u3001\u9f4b\u85e4 \u8aa0\u3001\u9053\u4e0a\u5927\u96c4\u3001\u9ad8\u91ce\u514b\u5df1\u3001\u6c96 \u660e\u5178\u3001\u8d64\u6728 \u7a76. \u5b50\u5bae\u4f53\u764c\u306b\u304a\u3051\u308bLynch\u75c7\u5019\u7fa4\uff08LS)\u306e\u30e6\u30cb\u30d0\u30fc\u30b5\u30eb\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u53ca\u3073\u907a\u4f1d\u5b50\u8a3a\u65ad. \u7b2c45\u56de\u65e5\u672c\u907a\u4f1d\u30ab\u30a6\u30f3\u30bb\u30ea\u30f3\u30b0\u5b66\u4f1a\uff08WEB)\u30002021.7.4<\/li>\n\n\n\n
              6. \u9053\u4e0a\u5927\u96c4\uff64\u9f4b\u85e4\u4ec1\u662d\uff64\u7530\u6751\u5927\u6a39\u3001\u67ff\u6cbc\u9e97\u65bc\u5948\u3001\u6a0b\u53e3\u5927\u6a39\u3001\u9ad8\u5c3e \u822a\u3001\u52a0\u85e4 \u656c\u3001\u6e21\u908a\u4f91\u5948\uff64\u7389\u4e95\u306f\u308b\u306a\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u9ad8\u91ce\u514b\u5df1\u3001\u98ef\u5d8b\u9054\u751f\u3001\u6c96 \u660e\u5178. \u5b50\u5bae\u9838\u90e8\u767a\u751f\u306e\u5c0f\u7d30\u80de\u764c\u3092\u4f34\u3046\u5185\u981a\u90e8\u578b\u817a\u764c\u306e\u4f53\u90e8\u6d78\u6f64\u304b\u3001\u5b50\u5bae\u4f53\u764c\u3068\u9838\u764c\u306e\u885d\u7a81\u764c\u304b\u8a3a\u65ad\u3057\u96e3\u3044\u4e00\u4f8b. \u7b2c63\u56de\u65e5\u672c\u5a66\u4eba\u79d1\u816b\u760d\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a(\u5927\u962a\/\u30cf\u30a4\u30d6\u30ea\u30c3\u30c9\uff092021. 7.16-18<\/li>\n\n\n\n
              7. \u5b89\u90e8\u52a0\u5948\u5b50\u3001\u9f4b \u6d0b\u5b50\u3001\u5742\u5834\u5927\u8f14\u3001\u4e94\u5473\u9999\u7e54\u3001\u9ad8\u5c3e \u822a\u3001\u52a0\u85e4 \u656c\u3001\u9053\u4e0a\u5927\u96c4\u3001\u9ad8\u91ce\u514b\u5df1\u3001\u6c96 \u660e\u5178. \u300c\u6388\u4e73\u3068\u304a\u304f\u3059\u308a\u5916\u6765\u300d\u7dcf\u8aac\u5f8c\u306e\u7cbe\u795e\u75be\u60a3\u5408\u4f75\u598a\u5a66\u306e\u6bcd\u4e73\u80b2\u5150\u306e\u73fe\u72b6\u5831\u544a. \u7b2c59\u56de\u81ea\u6cbb\u4f53\u75c5\u9662\u5b66\u4f1a(\u5948\u826f\/\u30cf\u30a4\u30d6\u30ea\u30c3\u30c9\uff09 2021.11.4-5<\/li>\n\n\n\n
              8. \u5742\u5834\u5927\u8f14\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u67ff\u6cbc\u9e97\u65bc\u5948\uff64\u4e94\u5473\u9999\u7e54\u3001\u9ad8\u5c3e \u822a\uff64\u52a0\u85e4 \u656c\uff64\u9053\u4e0a\u5927\u96c4\u3001\u9ad8\u91ce\u514b\u5df1\u3001\u6c96 \u660e\u5178. COVID-19\u6d41\u884c\u65e9\u671f\u306e\u7b2c3\u6ce2\u4e2d\u306b\u5f53\u9662\u3067\u598a\u5a20\u5206\u5a29\u7ba1\u7406\u3092\u884c\u3063\u305fCOVID-19\u5408\u4f75\u598a\u5a20\u306e2\u4f8b. \u7b2c189\u56de\u8328\u57ce\u770c\u7523\u79d1\u5a66\u4eba\u79d1\u5b66\u4f1a\u4f8b\u4f1a\uff08\u6c34\u6238\uff092019.11.16<\/li>\n\n\n\n
              9. \u5742\u5834\u5927\u8f14\u3001\u9053\u4e0a\u5927\u96c4\u3001\u4e94\u5473\u9999\u7e54\u3001\u67ff\u6cbc\u9e97\u65bc\u5948\u3001\u9ad8\u5c3e\u3000\u822a\uff64\u52a0\u85e4\u3000\u656c\u3001\u7389\u4e95\u6625\u5948\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u9ad8\u91ce\u514b\u5df1\u3001\u6c96\u3000\u660e\u5178. \u7247\u5074\u767a\u751f\u3067\u753b\u50cf\u4e0a\u5375\u5de3\u60aa\u6027\u816b\u760d\u304c\u7591\u308f\u308c\u305fHyperreactio Luteonalis\u306e\u4e00\u4f8b. \u7b2c14\uff11\u56de\u95a2\u6771\u9023\u5408\u7523\u5a66\u4eba\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a(WEB\uff092021.11.20<\/li>\n\n\n\n
              10. \u4e94\u5473\u9999\u7e54\u3001\u9ad8\u5c3e \u822a\u3001\u5742\u5834\u5927\u8f14\u3001\u67ff\u6cbc\u9e97\u65bc\u5948\u3001\u52a0\u85e4\u3000\u656c\u3001\u7389\u4e95\u306f\u308b\u306a\u3001\u9053\u4e0a\u5927\u96c4\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u9ad8\u91ce\u514b\u5df1\u3001\u6c96\u3000\u660e\u5178. \u60aa\u6027\u30ea\u30f3\u30d1\u816b\u306e\u65e2\u5f80\u304c\u3042\u308b\u3001\u540c\u6642\u60274\u91cd\u8907\u764c(\u5375\u5de3\u764c\u3001\u4e73\u764c\u3001\u80c3\u764c\u3001\u80c6\u7ba1\u764c)\u306e\u4e00\u4f8b. \u7b2c14\uff11\u56de\u95a2\u6771\u9023\u5408\u7523\u5a66\u4eba\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a(WEB\uff092021.11.20<\/li>\n\n\n\n
              11. \u9ad8\u91ce\u514b\u5df1\uff0c\u9053\u4e0a\u5927\u96c4\uff0c\u9ad8\u5c3e \u822a\uff0c\u52a0\u85e4 \u656c\uff0c\u67ff\u6cbc\u9e97\u65bc\u5948\u3001\u4e94\u5473\u9999\u7e54\uff0c\u5742\u5834\u5927\u8f14\uff0c\u5b89\u90e8\u52a0\u5948\u5b50\uff0c\u6c96 \u660e\u5178. \u30ed\u30dc\u30c3\u30c8\u624b\u8853\u306b\u304a\u3051\u308b\u958b\u8179\u8853\u65e2\u5f80\u306e\u3042\u308b\u75c7\u4f8b\u306b\u5bfe\u3059\u308b\u30aa\u30d7\u30c6\u30a3\u30ab\u30eb\u6cd5\u306e\u6709\u7528\u6027\uff5e\u958b\u8179\u65e2\u5f80\u306e\u80a5\u6e80\u75c7\u4f8b\u306b\u5bfe\u3059\u308b\u30dd\u30fc\u30c8\u8a2d\u7f6e\u306e\u5931\u6557\u3092\u7d4c\u9a13\u3057\u3066\uff5e. \u7b2c10\u56de\u65e5\u672c\u5a66\u4eba\u79d1\u30ed\u30dc\u30c3\u30c8\u624b\u8853\u5b66\u4f1a(\u9759\u5ca1\uff092022.1.29-30<\/li>\n\n\n\n
              12. \u67f3\u5ddd\u5fb9\u3001\u6c96 \u660e\u5178\u3001\u6301\u7530\u96c4\u5b50\u3001\u6c34\u91ce\u5b5d\u5b50\u3001\u677e\u91d1\u5948\u7dd2\u3001\u5e38\u4e95\u7531\u4f73\u5229\u3001\u5927\u6728\u5b8f\u4ecb\u3001\u91ce\u53e3\u7be4\u90ce\u3001\u8429\u539f\u654f\u4e4b\u3001\u5185\u7530\u6587\u5f66\u3001\u83c5\u91ce\u76f4\u7f8e\u3001\u5c71\u7e23\u61b2\u53f8\u3001\u5c0f\u5cf6 \u5bdb\u3001\u6b66\u5ddd\u5bdb\u6a39. \u8328\u57ce\u770c\u7acb\u4e2d\u592e\u75c5\u9662\u306b\u304a\u3051\u308b\u5468\u8853\u671f\u7b49\u53e3\u8154\u6a5f\u80fd\u7ba1\u7406\u306e\u6709\u52b9\u6027\u306e\u8a55\u4fa1\u30fc\u5a66\u4eba\u79d1\u60aa\u6027\u816b\u760d\u60a3\u8005\u306b\u304a\u3051\u308b\u6709\u52b9\u6027\u306b\u3064\u3044\u3066. \u7b2c30\u56de\u8328\u57ce\u770c\u6b6f\u79d1\u533b\u5b66\u4f1a(\u6c34\u6238\uff09\u30002022.3.13<\/li>\n<\/ol>\n\n\n\n

                \u4ee4\u548c2\u5e74\u5ea6<\/h3>\n\n\n\n

                \u3010\u8ad6\u6587\u3011<\/p>\n\n\n\n

                  \n
                1. \u6e21\u908a\u660e\u6075\u3001\u9ad8\u91ce\u514b\u5df1\u3001\u9234\u6728\u3042\u3059\u304b\u3001\u6d25\u66f2\u7dbe\u5b50\u3001\u68ee \u60a0\u6a39\u3001\u5c71\u53e3\u307e\u3069\u304b\u3001\u85e4\u679d \u85ab\u3001\u9ad8\u5c3e \u822a\u3001\u7389\u4e95\u306f\u308b\u306a\u3001\u9053\u4e0a\u5927\u96c4\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u6f06\u5ddd \u90a6\u3001\u6c96 \u660e\u5178. \u6210\u4eba\u5f8c\u306b\u8a3a\u65ad\u3055\u308c\u3001Informed Consent\u3084\u5bfe\u5fdc\u306b\u5de5\u592b\u3092\u8981\u3057\u305f Swyer \u75c7\u5019\u7fa4\u306e 1 \u4f8b. \u95a2\u6771\u7523\u5a66\u8a8c 57: 67-74, 2020\uff081 \u6708\uff09<\/li>\n\n\n\n
                2. \u539f \u7d62\u9999\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u4e45\u4fdd\u8c37\u8a17\u4e5f\u3001\u9ad8\u5c3e \u822a\u3001\u7389\u4e95\u306f\u308b\u306a\u3001\u9053\u4e0a\u5927\u96c4\u3001\u5152\u7389 \u7406\u3001\u9ad8\u91ce\u514b\u5df1\u3001\u6c96 \u660e\u5178\u3001\u5409\u5ddd\u88d5\u4e4b. \u80ce\u5150\u5f90\u8108\u306e\u8a3a\u65ad\u3067\u7dca\u6025\u5e1d\u738b\u5207\u958b\u3068\u306a\u3063\u305f\u975e\u7622\u75d5\u5b50\u5bae\u7834\u88c2\u306e\u4e00\u4f8b\uff5e\u305d\u306e\u8a3a\u65ad\u3068\u5bfe\u5fdc\u306b\u3064\u3044\u3066\u306e\u691c\u8a0e\uff5e. \u8328\u57ce\u770c\u7acb\u75c5\u9662\u533b\u5b66\u96d1\u8a8c(36) 2 : 31-38, 2020\uff083 \u6708\uff09<\/li>\n\n\n\n
                3. \u5c0f\u4e95\u6238\u7dbe\u5b50\u3001\u5185\u7530\u597d\u660e\uff64\u963f\u90e8\u9999\u7e54\u3001\u65b0\u767a\u7530\u96c5\u6674\u3001\u53e4\u6751\u7950\u7d00\u3001\u5b89\u7530\u771f\u5927\u3001\u9ad8\u91ce\u514b\u5df1\u3001\u6c96 \u660e\u5178\u3001\u6589\u85e4\u4ec1\u662d\uff64\u98ef\u5d8b\u9054\u751f\uff64\u4e95\u6751\u7a70\u4e8c. \u5b50\u5bae\u4f53\u90e8\u539f\u767a\u5c0f\u7d30\u80de\u795e\u7d4c\u5185\u5206\u6ccc\u7d30\u80de\u764c\u306e\uff11\u4f8b. \u8328\u57ce\u770c\u7acb\u75c5\u9662\u533b\u5b66\u96d1\u8a8c(37) 1: 31-36, 2020\uff089 \u6708\uff09<\/li>\n\n\n\n
                4. Yosuke Konno, Hiroshi Asano, Ayumi Shikama, Daisuke Aoki, Michihiro Tanikawa, Akinori Oki, Koji Horie, Akira Mitsuhashi, Akira Kikuchi, Hideki Tokunaga, Yasuhisa Terao, Toyomi Satoh, Kimio Ushijima, Mitsuya Ishikawa, Nobuo Yaegashi, Hidemichi Watari. Lymphadenectomy issues in endometrial cancer. JOURNAL OF GYNECOLOGIC ONCOLOGY\/32(2), 2021-03<\/li>\n<\/ol>\n\n\n\n

                  \u3010\u5b66\u4f1a\u5831\u544a\u3011<\/p>\n\n\n\n

                    \n
                  1. \u9053\u4e0a \u5927\u96c4, \u4e45\u4fdd\u8c37 \u8a17\u4e5f, \u539f \u7d62\u9999, \u9ad8\u5c3e \u822a, \u7389\u4e95 \u306f\u308b\u306a, \u5152\u7389 \u7406, \u5b89\u90e8 \u52a0\u5948\u5b50, \u9ad8\u91ce \u514b\u5df1, \u6c96 \u660e\u5178. \u30df\u30b9\u30de\u30c3\u30c1\u4fee\u5fa9\u30bf\u30f3\u30d1\u30af\u306e status \u3092\u8003\u616e\u3057\u305f\u5b50\u5bae\u4f53\u764c\u306e\u6cbb\u7642\u6226\u7565. \u7b2c 72 \u56de\u65e5\u672c\u7523\u79d1\u5a66\u4eba\u79d1\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a\uff08\u6771\u4eac\uff0fWEB \u958b\u50ac\uff092020.4<\/li>\n\n\n\n
                  2. \u77f3\u5802 \u4f73\u4e16, \u6c96 \u660e\u5178, \u9ad8\u91ce \u514b\u5df1, \u9053\u4e0a \u5927\u96c4, \u9f4b\u85e4 \u8aa0, \u8d64\u6728 \u7a76. \u5b50\u5bae\u4f53\u304c\u3093\u3088\u308a\u30ea\u30f3\u30c1\u75c7\u5019\u7fa4\u3092\u62fe\u3044\u4e0a\u3052\u308b\u305f\u3081\u306e APF \u57fa\u6e96\u6709\u7528\u6027\u306e\u691c\u8a0e. \u7b2c 26 \u56de\u65e5\u672c\u907a\u4f1d\u6027\u816b\u760d\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a(WEB \u958b\u50ac\uff092020.8.21-31<\/li>\n\n\n\n
                  3. \u77f3\u5802\u4f73\u4e16\u3001\u5b89\u7530\u6709\u7406\u3001\u658e\u85e4 \u8aa0\u3001\u5c0f\u4e95\u6238\u7dbe\u5b50\u3001\u963f\u90e8\u9999\u7e54\u3001\u6c96 \u660e\u5178\u3001\u98ef\u5cf6\u9054\u96c4. \u5b50\u5bae\u4f53\u764c\u306b\u304a\u3051\u308b\u30e6\u30cb\u30d0\u30fc\u30b5\u30eb\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u306b\u3088\u308b Lynch \u75c7\u5019\u7fa4\u691c\u51fa\u7387\u306e\u5411\u4e0a\u3078\u306e\u53d6\u308a\u7d44\u307f. \u7b2c 25 \u56de\u65e5\u672c\u5bb6\u65cf\u6027\u816b\u760d\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a(\u6771\u4eac\uff092020.8.21-31<\/li>\n\n\n\n
                  4. \u7530\u6751\u5927\u6a39\u3001\u9ad8\u91ce\u514b\u5df1\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u5152\u7389 \u7406\u3001\u9053\u4e0a\u5927\u96c4\u3001\u7389\u4e95\u306f\u308b\u306a\uff64\u9ad8\u5c3e \u822a\u3001\u539f \u7d62\u9999\u3001\u6a0b\u53e3\u5927\u6a39\u3001\u6c96 \u660e\u5178. \u5f53\u9662\u3067\u7d4c\u9a13\u3057\u305f\u6210\u719f\u56a2\u80de\u6027\u5947\u5f62\u816b\u306e\u60aa\u6027\u8ee2\u5316 6 \u4f8b\u306e\u691c\u8a0e. \u7b2c 140 \u56de\u95a2\u6771\u9023\u5408\u7523\u5a66\u4eba\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a(\u3064\u304f\u3070\/WEB\uff092020. 11<\/li>\n\n\n\n
                  5. \u6a0b\u53e3\u5927\u6a39\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u7530\u6751\u5927\u6a39\u3001\u539f \u7d62\u9999\u3001\u9ad8\u5c3e \u822a\u3001\u7389\u4e95\u306f\u308b\u306a\u3001\u9053\u4e0a\u5927\u96c4\u3001\u5152\u7389 \u7406\u3001\u9ad8\u91ce\u514b\u5df1\u3001\u6c96 \u660e\u5178\uff0e\u5f53\u9662\u3067\u306e\u82e5\u5e74\u598a\u5a20 16 \u4f8b\u306e\u793e\u4f1a\u7684\u80cc\u666f\u306e\u5f8c\u65b9\u8996\u7684\u691c\u8a0e\uff0e\u7b2c 140 \u56de\u95a2\u6771\u9023\u5408\u7523\u5a66\u4eba\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff08\u3064\u304f\u3070\/WEB\uff092020.11<\/li>\n\n\n\n
                  6. \u9ad8\u5c3e \u822a\uff64\u9ad8\u91ce\u514b\u5df1\u3001\u4e45\u4fdd\u8c37\u8a17\u4e5f\u3001\u539f \u7d62\u9999\u3001\u7389\u4e95\u306f\u308b\u306a\u3001\u9053\u4e0a\u5927\u96c4\u3001\u5152\u7389 \u7406\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u6c96 \u660e\u5178\u3001\u5409\u5ddd\u88d5\u4e4b. \u5f53\u9662\u306b\u304a\u3051\u308b\u65e9\u671f\u5b50\u5bae\u4f53\u764c\u306b\u5bfe\u3059\u308b\u93e1\u8996\u4e0b\u624b\u8853\u306e\u6cbb\u7642\u6210\u7e3e. \u7b2c 62 \u56de\u65e5\u672c\u5a66\u4eba\u79d1\u816b\u760d\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a(\u4ed9\u53f0\/WEB\uff092021. 1.29-30<\/li>\n\n\n\n
                  7. \u9053\u4e0a\u5927\u96c4\u3001\u77f3\u9ed2\u614e\u543e\u3001\u4e45\u4fdd\u8c37\u8a17\u4e5f\u3001\u539f \u7d62\u9999\u3001\u9ad8\u5c3e \u822a\uff64\u7389\u4e95\u306f\u308b\u306a\u3001\u5152\u7389 \u7406\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u9ad8\u91ce\u514b\u5df1\u3001\u77f3\u5802\u4f73\u4e16\u3001\u9f4b\u85e4 \u8aa0\u3001\u6c96 \u660e\u5178. Pembrolizumab \u306b\u3088\u308a\u90e8\u5206\u594f\u529f\u304c\u5f97\u3089\u308c\u3066\u3044\u308b\uff64\u96e3\u6cbb\u6027\u5b50\u5bae\u4f53\u764c\u306e\u4e00\u4f8b. \u7b2c 62 \u56de\u65e5\u672c\u5a66\u4eba\u79d1\u816b\u760d\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a(\u4ed9\u53f0\/WEB\uff092021. 1.29-30<\/li>\n<\/ol>\n\n\n\n

                    \u3010\u8b1b\u6f14\u3011<\/p>\n\n\n\n

                      \n
                    1. \u6c96 \u660e\u5178. \u81e8\u5e8a\u691c\u67fb\u306b\u304a\u3051\u308b\u30ea\u30f3\u30c1\u75c7\u5019\u7fa4\u5468\u8fba\u306e\u6700\u8fd1\u306e\u8a71\u984c(\u81e8\u5e8a\u533b\u306e\u7acb\u5834\u304b\u3089\uff09.2019 \u5e74\u5ea6\u7b2c3\u56de\u8328\u57ce\u770c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u7814\u4fee\u4f1a(\u7b20\u9593\uff092020.1.19<\/li>\n\n\n\n
                    2. \u9053\u4e0a\u5927\u96c4. \u30bb\u30d7\u30e9\u30d5\u30a3\u30eb\u30e0\u4f7f\u7528\u306b\u304a\u3051\u308b\u30d4\u30c3\u30c8\u30d5\u30a9\u30fc\u30eb. \u8328\u57ce\u770c\u7523\u5a66\u4eba\u79d1\u5468\u8853\u671f\u5408\u4f75\u75c7\u7814\u7a76\u4f1a(\u3064\u304f\u3070\uff092020.1.23<\/li>\n\n\n\n
                    3. \u9ad8\u91ce\u514b\u5df1. \uff5e\u958b\u8179\u4e16\u4ee3\u3067\u3082\u3084\u308c\u3070\u3067\u304d\u308b\uff5e\u5185\u8996\u93e1\u624b\u8853\u5f8c\u9032\u770c\u306e\u5a66\u4eba\u79d1\u816b\u760d\u533b\u306e\u5185\u8996\u93e1\u6280\u8853\u8a8d\u5b9a\u533b\u53d6\u5f97\u7d4c\u9a13. \u7b2c 140 \u56de\u95a2\u6771\u9023\u5408\u7523\u5a66\u4eba\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a(\u3064\u304f\u3070\/WEB\uff092020. 11<\/li>\n\n\n\n
                    4. \u7530\u6751\u5927\u6a39\u3001\u9ad8\u91ce\u514b\u5df1. TLH \u57f7\u5200\u3092\u7d4c\u9a13\u3057\u3066. \u7b2c\uff12\u56de\u8328\u57ce\u770c\u5a66\u4eba\u79d1\u5185\u8996\u93e1\u306e\u4f1a<\/li>\n\n\n\n
                    5. \u4f50\u85e4\u664b\u723e\u3001\u5b89\u90e8\u52a0\u5948\u5b50\uff64\u9f4b \u6d0b\u5b50\u3001\u77e2\u53e3\u5c1a\u5b50. \u6b1d\u3068\u4e0d\u5b89\u3092\u5b66\u3073\u306a\u304a\u305d\u3046\uff01\u7b2c 5 \u56de\u8328\u57ce\u5468\u7523\u671f\u30e1\u30f3\u30bf\u30eb\u30d8\u30eb\u30b9\u7814\u7a76\u4f1a<\/li>\n<\/ol>\n\n\n\n

                      \u4ee4\u548c\u5143\u5e74\u5ea6<\/h3>\n\n\n\n

                      \u3010\u8ad6\u6587\u3011<\/p>\n\n\n\n

                        \n
                      1. \u9ad8\u91ce\u514b\u5df1\u3001\u6c96 \u660e\u5178\u3001\u5c0f\u5cf6\u4f51\u57fa\u3001\u6d25\u66f2\u7dbe\u5b50\u3001\u85e4\u679d \u85ab\u3001\u5c71\u53e3\u307e\u3069\u304b\u3001\u7389\u4e95\u306f\u308b\u306a\u3001\u9053\u4e0a\u5927\u96c4\u3001\u79cb\u5c71 \u6893\u3001 \u5b89\u90e8\u52a0\u5948\u5b50\u3001\u6f06\u5ddd \u90a6\u3001\u8d8a\u667a\u5bdb\u5e78\u3001 \u5409\u5ddd\u88d5\u4e4b\uff1a\u5185\u8996\u93e1\u6280\u8853\u8a8d\u5b9a\u533b\u306e\u3044\u306a\u3044\u65bd\u8a2d\u3067\u306e\u8179\u8154\u93e1\u4e0b\u5b50\u5bae\u5168 \u6458\u8853\u306e\u5c0e\u5165\u7d4c\u9a13\u3001\u95a2\u6771\u7523\u5a66\u8a8c\u300156: 27-34, 2019<\/li>\n\n\n\n
                      2. \u9ad8\u91ce\u514b\u5df1\u3001\u9f4b\u85e4\u8aa0\u3001\u5b89\u7530\u6709\u7406\uff64\u77f3\u5802\u4f73\u4e16\u3001\u6e21\u908a\u660e\u6075\u3001\u9234\u6728\u3042\u3059\u304b\u3001\u9ad8\u5c3e\u822a\uff64\u7389\u4e95\u306f\u308b\u306a\u3001\u9053\u4e0a\u5927\u96c4\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u6f06\u5ddd\u90a6\uff64\u6c96\u660e\u5178\u3001\u5409\u5ddd\u88d5\u4e4b\uff1a\u8179\u8154\u93e1\u65bd\u884c\u6642\u306b IIIC \u671f\u3060\u3063\u305f BRCA2 \u5909\u7570\u967d\u6027\u5375\u7ba1\u764c\u306e 1 \u4f8b\u3001\u8328\u57ce\u770c\u7acb\u75c5\u9662\u533b\u5b66\u96d1\u8a8c\u3001(35) 2 :21-26, 2019(3 \u6708\uff09<\/li>\n\n\n\n
                      3. \u5c0f\u5cf6\u4f51\u57fa\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u9ad8\u5c3e \u822a\u3001\u9053\u4e0a\u5927\u96c4\u3001\u6f06\u5ddd \u90a6\u3001\u9ad8\u91ce\u514b\u5df1\u3001\u79cb\u5c71\u9806\u5b50\u3001\u6c96 \u660e\u5178\uff1a\u4f4e\u30ea\u30b9\u30af\u598a\u5a66\u306b\u767a\u75c7\u3057\u305f\u5206\u5a29\u5b50\u7647\u75c7\u4f8b\u306e\u691c\u8a0e\u304b\u3089\u4f5c\u6210\u3057\u305f\u598a\u7523\u5a66\u306e\u6025\u5909\u5bfe\u5fdc\u30de\u30cb\u30e5\u30a2\u30eb.\u306e\u4f5c\u6210\u7d4c\u9a13\u3001\u8328\u57ce \u770c\u6bcd\u6027\u885b\u751f\u5b66\u4f1a\u8a8c\u300137: 41-46, 2019\uff083 \u6708\uff09<\/li>\n\n\n\n
                      4. \u9ad8\u91ce\u514b\u5df1\u3001\u9ad8\u5c3e \u822a\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u6f06\u5ddd \u90a6\uff1a\u8179\u8154\u93e1\u7528\u30c8\u30ed\u30c3\u30ab\u30fc\u30d0\u30eb\u30d6\u7834\u640d\u306e\u7d4c\u9a13\u3001\u65e5\u672c\u7523\u79d1\u5a66\u4eba \u79d1\u5185\u8996\u93e1\u5b66\u4f1a\u96d1\u8a8c\u300135(1): 153-157, 2019<\/li>\n\n\n\n
                      5. Matsumoto K, Yaegashi N, Iwata T, Yamamoto K, Aoki Y, Okadome M, Ushijima K, Kamiura S, Takehara K, Horie K, Tasaka N, Sonoda K, Takei Y, Aoki Y, Konnai K, Katabuchi H, Nakamura K, Ishikawa M, Watari H, Yoshida H, Matsumura N, Nakai H, Shigeta S, Takahashi F, Noda K, Yoshikawa H. Reduction in HPV16\/18 prevalence among young women with high-grade cervical lesions following the Japanese HPV vaccination program. Cancer Sci, 110(12): 3811-3820, 2019<\/li>\n\n\n\n
                      6. Kawasaki A, Itagaki H, Tsumagari A, Ijiri H, Yoshikawa, H, Satoh T. Four cases of MayerRokitansky- K\u00fcster-Hauser syndrome treated via non-surgical vaginal reconstruction using uterine cervical dilators. The Journal of Obstetrics and Gynaecology Research, Dec 19. doi: 10.1111\/jog.14180.<\/li>\n\n\n\n
                      7. \u6e21\u908a\u660e\u6075\u3001\u9ad8\u91ce\u514b\u5df1\u3001\u9234\u6728\u3042\u3059\u304b\u3001\u6d25\u66f2\u7dbe\u5b50\u3001\u68ee \u60a0\u6a39\u3001\u5c71\u53e3\u307e\u3069\u304b\u3001\u85e4\u679d \u85ab\u3001\u9ad8\u5c3e \u822a\u3001\u7389\u4e95\u306f\u308b\u306a\u3001\u9053\u4e0a\u5927\u96c4\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u6f06\u5ddd \u90a6\u3001\u6c96 \u660e\u5178\uff1ainformed consent \u306b\u82e6\u616e\u3057\u305f\u6210\u4eba\u5f8c\u306b\u8a3a\u65ad\u3055\u308c \u305f Swyer \u75c7\u5019\u7fa4\u306e 1 \u4f8b\u3001\u95a2\u6771\u7523\u5a66\u8a8c\u300157\uff081\uff09\uff1a67\u221274\u30012020\uff081 \u6708\uff09<\/li>\n<\/ol>\n\n\n\n

                        \u3010\u5b66\u4f1a\u5831\u544a\u3011<\/p>\n\n\n\n

                          \n
                        1. \u9577\u4e95 \u88d5\u3001\u4e09\u4e0a\u5e79\u7537\u3001\u559c\u591a\u5ddd \u4eae\u3001\u6238\u6fa4\u6643\u5b50\u3001\u5c0f\u6797\u69ae\u4ec1\u3001\u5bae\u57ce\u60a6\u5b50\u3001\u6a2a\u7530\u6cbb\u91cd\u3001\u9752\u6728\u967d\u4e00\u3001\u5ca9\u7028\u6625\u5b50\u3001 \u5c71\u53e3 \u8061\u3001\u82db\u539f \u7a14\u3001\u6a2a\u5c71\u6b63\u4fca\u3001\u516b\u91cd\u6a2b\u4f38\u751f\u3001\u5897\u5c71 \u5bff\u3001\u7af9\u539f\u548c\u5b8f\uff64\u4e2d\u6751\u4fca\u662d\u3001\u7530\u7551 \u52d9\u3001\u4e0a\u6d66\u7965\u53f8\u3001\u5ca9 \u4f50\u5c1a\u7f8e\u3001\u5e73\u6fa4 \u731b\u3001\u6749\u91ce\u6cd5\u5e83\u3001\u5869\u6ca2\u4e39\u91cc\u3001\u5c0f\u6797 \u6d69\u3001\u677e\u5143 \u9686\u3001\u68ee\u91cd\u5065\u4e00\u90ce\u3001\u5317 \u6b63\u4eba\u3001\u677f\u6301\u5e83\u660e\uff64\u83ca\u6c60 \u6717\uff64\u6749\u6d66\u771f\u5f13\u3001\u85e4\u539f\u8449\u4e00\u90ce\u3001\u5fb3\u5c71 \u6cbb\u3001\u5927\u77f3\u5fb9\u90ce\u3001\u5c0f\u6797\u88d5\u660e\u3001\u6e21\u5229\u82f1\u9053\u3001\u6c34\u91ce\u7f8e\u9999\u3001\u5409\u7530\u597d\u96c4\u3001\u6751\u4e0a\u6587 \u6d0b\u3001\u9ad8\u6a4b\u6176\u884c\uff64\u6a2a\u4e95 \u731b\u3001\u6a3d\u539f\u4e45\u53f8\u3001\u5c0f\u5bfa\u5b8f\u5e73\u3001\u6a2a\u5c71\u826f\u4ec1\u3001\u6c96 \u660e\u5178\u3001\u6c34\u4e4b\u6c5f\u77e5\u54c9\u3001\u6749\u5c71 \u5fb9\uff0e \u5b50\u5bae\u9838 \u90e8\u817a\u764c\u306b\u5bfe\u3059\u308b\u540c\u6642\u5316\u5b66\u653e\u5c04\u7dda\u7642\u6cd5\u306b\u95a2\u3059\u308b\u4ed6\u65bd\u8a2d\u5171\u540c\u8abf\u67fb\u7814\u7a76\uff0e\u7b2c 71\u56de\u65e5\u672c\u7523\u79d1\u5a66\u4eba\u79d1\u5b66\u4f1a\u5b66\u8853 \u8b1b\u6f14\u4f1a\u30012019.4\uff08\u540d\u53e4\u5c4b\uff09<\/li>\n\n\n\n
                        2. \u6f06\u5ddd \u90a6\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u6e21\u908a\u660e\u6075\u3001\u9234\u6728\u3042\u3059\u304b\uff64\u9ad8\u5c3e \u822a\uff64\u9053\u4e0a\u5927\u96c4\u3001\u9ad8\u91ce\u514b\u5df1\u3001\u6c96 \u660e\u5178\u3001\u5409\u5ddd\u88d5\u4e4b\uff0e \u5f53\u9662\u306b\u304a\u3051\u308b\u5411\u7cbe\u795e\u85ac\u30fb\u7cbe\u795e\u75c5\u85ac\u3092\u5185\u670d\u4e2d\u306e\u598a\u5a66\u304b\u3089\u51fa\u751f\u3057\u305f\u5150\u306e\u77ed\u671f\u4e88\u5f8c\uff0e\u7b2c 71 \u56de\u65e5\u672c\u7523\u79d1\u5a66\u4eba \u79d1\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a\u30012019.4\uff08\u540d\u53e4\u5c4b\uff09<\/li>\n\n\n\n
                        3. \u9053\u4e0a\u5927\u96c4\u3001\u6c96 \u660e\u5178\u3001\u6e21\u908a\u660e\u6075\u3001\u9234\u6728\u3042\u3059\u304b\u3001\u9ad8\u5c3e \u822a\u3001\u7389\u4e95\u306f\u308b\u306a\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u6f06\u5ddd \u90a6\uff64\u9ad8\u91ce\u514b\u5df1\u3001 \u5409\u5ddd\u88d5\u4e4b\uff0e\u5f53\u9662\u306b\u304a\u3051\u308b\u5375\u5de3\u764c\u30fb\u8179\u819c\u764c\u306b\u5bfe\u3059\u308b second line \u3068\u3057\u3066\u306e DocetaxelCarboplatin \u7642\u6cd5 \u306e\u5f8c\u65b9\u8996\u7684\u691c\u8a0e\uff0e\u7b2c 71 \u56de\u65e5\u672c\u7523\u79d1\u5a66\u4eba\u79d1\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a\u30012019.4.\uff08\u540d\u53e4\u5c4b\uff09<\/li>\n\n\n\n
                        4. \u4e45\u4fdd\u8c37\u8a17\u4e5f\u3001\u9053\u4e0a\u5927\u96c4\u3001\u77f3\u9ed2\u614e\u543e\u3001\u6e21\u908a\u660e\u6075\u3001\u9234\u6728\u3042\u3059\u304b\u3001\u9ad8\u5c3e \u822a\uff64\u7389\u4e95\u306f\u308b\u306a\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u6f06\u5ddd \u90a6\uff64\u9ad8\u91ce\u514b\u5df1\u3001\u6c96 \u660e\u5178\uff0e\u80ba\u8ee2\u79fb\u3092\u8a8d\u3081\u308b\u5916\u9670\u60aa\u6027\u9ed2\u8272\u816b\u306b\uff64\u514d\u75ab\u30c1\u30a7\u30c3\u30af\u30dd\u30a4\u30f3\u30c8\u963b\u5bb3\u85ac\u306b\u3088\u308b\u7121\u5897 \u60aa\u751f\u5b58\u304c\u5f97\u3089\u308c\u3066\u3044\u308b\u4e00\u4f8b\uff0e\u7b2c 13\uff17\u56de\u95a2\u6771\u9023\u5408\u7523\u79d1\u5a66\u4eba\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30012019.6(\u6771\u4eac\uff09<\/li>\n\n\n\n
                        5. \u77f3\u5802\u4f73\u4e16\u3001\u9053\u4e0a\u5927\u96c4\u3001\u9ad8\u91ce\u514b\u5df1\u3001\u6c96 \u660e\u5178\u3001\u9f4b\u85e4 \u8aa0\u3001\u5b89\u7530\u6709\u91cc\u3001\u8d64\u6728 \u7a76\uff0e\u5b50\u5bae\u4f53\u764c\u304b\u3089 Lynch\u75c7\u5019 \u7fa4\u3068\u8a3a\u65ad\u3055\u308c\u305f\u767a\u7aef\u8005\u304b\u3089\u306e\u60c5\u5831\u63d0\u4f9b\u30fc\u8840\u7e01\u8005 8 \u540d\u306e\u907a\u4f1d\u5b66\u7684\u691c\u67fb\u53d7\u691c\u30fc\uff0e\u7b2c 25 \u56de\u65e5\u672c\u5bb6\u65cf\u6027\u816b\u760d \u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30012019.6(\u6771\u4eac\uff09<\/li>\n\n\n\n
                        6. \u77f3\u5802\u4f73\u4e16\u3001\u9f4b\u85e4 \u8aa0\u3001\u9053\u4e0a\u5927\u96c4\u3001\u9ad8\u91ce\u514b\u5df1\u3001\u6c96\u660e \u5178. Lynch \u75c7\u5019\u7fa4(LS)\u5bb6\u7cfb\u54e1\u306e\u767a\u75c7\u524d\u8a3a\u65ad\u3067\u7d4c\u9a13\u3057 \u305f\u5bb6\u7cfb\u5185\u306e\u591a\u69d8\u306a\u554f\u984c\u70b9\uff0e\u7b2c 43 \u56de\u65e5\u672c\u907a\u4f1d\u5b50\u30ab\u30a6\u30f3\u30bb\u30ea\u30f3\u30b0\u5b66\u4f1a\u30fb\u7b2c 26 \u56de\u65e5\u672c\u907a\u4f1d\u5b50\u8a3a\u7642\u5b66\u4f1a\u3001 2019.8(\u672d\u5e4c)<\/li>\n\n\n\n
                        7. \u539f \u7d62\u9999\u3001\u9ad8\u91ce\u514b\u5df1\u3001\u4e45\u4fdd\u8c37\u8a17\u4e5f\u3001\u9ad8\u5c3e \u822a\uff64\u7389\u4e95\u306f\u308b\u306a\u3001\u9053\u4e0a\u5927\u96c4\u3001\u5152\u7389 \u7406\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u6c96 \u660e\u5178\u3001 \u5409\u5ddd\u88d5\u4e4b\uff0e\u521d\u767a\u30fb\u518d\u767a\u6642\u306b\u76ae\u819a\u75c7\u72b6\u3092\u5448\u3057\u305f\u6297 TIF1-\u03b3 \u6297\u4f53\u967d\u6027\u76ae\u819a\u7b4b\u708e\u5408\u4f75\u8179\u819c\u764c\u30fb\u809d\u7d30\u80de\u764c\u306e\u4e00 \u4f8b\uff0e\u7b2c 134 \u56de\u95a2\u6771\u9023\u5408\u7523\u5a66\u4eba\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30012019.10(\u524d\u6a4b\uff09<\/li>\n\n\n\n
                        8. \u9053\u4e0a\u5927\u96c4\u3001\u4e45\u4fdd\u8c37\u8a17\u4e5f\u3001\u539f \u7d62\u9999\u3001\u9ad8\u5c3e \u822a\uff64\u7389\u4e95\u306f\u308b\u306a\u3001\u5152\u7389 \u7406\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u9ad8\u91ce\u514b\u5df1\u3001\u77f3\u5802\u4f73\u4e16\u3001 \u658e\u85e4 \u8aa0\u3001\u6c96 \u660e\u5178\uff0e\u5b50\u5bae\u4f53\u764c\u306b\u5bfe\u3059\u308b\u30ea\u30f3\u30c1\u75c7\u5019\u7fa4(LS)\u306e\u30e6\u30cb\u30d0\u30fc\u30b5\u30eb\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\uff08US)\u306e\u52b9\u7528\uff0e \u7b2c 134 \u56de\u95a2\u6771\u9023\u5408\u7523\u5a66\u4eba\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30012019.10(\u524d\u6a4b\uff09<\/li>\n\n\n\n
                        9. \u5150\u7389 \u7406\u3001\u7167\u5c4b\u6d69\u5b9f\u3001\u8db3\u7acb\u7d50\u83ef\u3001\u9808\u85e4\u512a\u5b50\u3001\u52a0\u85e4 \u656c\u3001\u4eba\u898b\u7fa9\u90ce\u3001\u4e2d\u6751\u4f73\u5b50\u3001\u5c71\u7530\u76f4\u6a39\u3001\u85e4\u6728 \u8c4a\uff0e\u30c1\u30e7\u30b3\u30ec\u30fc\u30c8\u56a2\u80de\u3088\u308a\u767a\u751f\u3057\u3001\u6025\u6fc0\u306b\u5897\u5927\u3057\u305f\u5375\u5de3\u6241\u5e73\u4e0a\u76ae\u764c\u306e\u4e00\u4f8b\uff0e\u7b2c 134 \u56de\u95a2\u6771\u9023\u5408\u7523\u5a66\u4eba\u79d1\u5b66 \u4f1a\u5b66\u8853\u96c6\u4f1a\u30012019.10(\u524d\u6a4b\uff09<\/li>\n\n\n\n
                        10. \u79cb\u5c71\u9806\u5b50\u3001\u9f4b \u6d0b\u5b50\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u658e\u85e4 \u8aa0\u3001\u4f50\u85e4\u664b\u723e\uff64\u9752\u5c71\u4e00\u7d00\u3001\u6c96 \u660e\u5178\uff0e\u516c\u7acb\u75c5\u9662\u306b\u304a\u3051\u308b\u8981\u652f\u63f4 \u598a\u7523\u5a66\u3078\u306e\u5730\u57df\u3068\u306e\u4ed6\u8077\u7a2e\u9023\u643a\u4f1a\u8b70\u306e\u5b9f\u614b\u3068\u6210\u679c\uff0e\u7b2c 58 \u56de\u5168\u56fd\u81ea\u6cbb\u4f53\u75c5\u9662\u5b66\u4f1a\u30012019.10(\u5fb3\u5cf6)<\/li>\n\n\n\n
                        11. \u9752\u5c71\u4e00\u7d00\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u658e\u85e4 \u8aa0\u3001\u79cb\u5c71\u9806\u5b50\u3001\u9f4b \u6d0b\u5b50\u3001\u5c71\u4e0b\u771f\u4ee5\u3001\u5c0f\u68ee\u7f8e\u7a42\u5b50\u3001\u9234\u6728\u7f8e\u52a0\uff0e\u85ac\u5264\u5e2b\u306b\u3088\u308b\u6388\u4e73\u3068\u304a\u304f\u3059\u308a\u5916\u6765\u304c\u85ac\u3092\u670d\u7528\u3057\u3066\u3044\u308b\u598a\u5a66\u3078\u306e\u6bcd\u4e73\u80b2\u5150\u306b\u4e0e\u3048\u308b\u5f71\u97ff\u306b\u3064\u3044\u3066\uff0e\u7b2c58 \u56de\u5168\u56fd \u81ea\u6cbb\u4f53\u75c5\u9662\u5b66\u4f1a\u30012019.10(\u5fb3\u5cf6)<\/li>\n\n\n\n
                        12. \u539f \u7d62\u9999\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u4e45\u4fdd\u8c37\u8a17\u4e5f\u3001\u9ad8\u5c3e \u822a\u3001\u7389\u4e95\u306f\u308b\u306a\u3001\u9053\u4e0a\u5927\u96c4\u3001\u5150\u7389 \u7406\u3001\u9ad8\u91ce\u514b\u5df1\u3001\u6c96 \u660e\u5178\u3001 \u5409\u5ddd\u88d5\u4e4b\uff0eunscared uterus \u306e\u5b50\u5bae\u7834\u88c2\u306e\u4e00\u4f8b\uff0e\u7b2c 189 \u56de\u8328\u57ce\u770c\u7523\u79d1\u5a66\u4eba\u79d1\u5b66\u4f1a\u4f8b\u4f1a\u30012019.11(\u6c34\u6238)<\/li>\n<\/ol>\n\n\n\n

                          \u3010\u8b1b\u6f14\u3011<\/p>\n\n\n\n

                            \n
                          1. \u4e45\u4fdd\u8c37\u8a17\u4e5f\uff0e\u5f53\u79d1\u306b\u304a\u3051\u308b VTE \u306b\u5bfe\u3059\u308b\u6cbb\u7642\u6226\u7565\uff5e\u4e88\u9632\u3068\u6cbb\u7642\uff5e\uff0e\u3044\u3070\u3089\u304d VTE \u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u3001 2019.11(\u53cb\u90e8\uff09<\/li>\n\n\n\n
                          2. \u6c96 \u660e\u5178\uff0e\u81e8\u5e8a\u691c\u67fb\u306b\u304a\u3051\u308b\u30ea\u30f3\u30c1\u75c7\u5019\u7fa4\u5468\u8fba\u306e\u6700\u8fd1\u306e\u8a71\u984c(\u81e8\u5e8a\u533b\u306e\u7acb\u5834\u304b\u3089\uff09\uff0e2019 \u5e74\u5ea6\u7b2c3\u56de \u8328\u57ce\u770c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u7814\u4fee\u4f1a\u30012020.1(\u7b20\u9593\uff09<\/li>\n\n\n\n
                          3. \u9053\u4e0a\u5927\u96c4\uff0e\u30bb\u30d7\u30e9\u30d5\u30a3\u30eb\u30e0\u4f7f\u7528\u306b\u304a\u3051\u308b\u30d4\u30c3\u30c8\u30d5\u30a9\u30fc\u30eb\uff0e\u8328\u57ce\u770c\u7523\u5a66\u4eba\u79d1\u5468\u8853\u671f\u5408\u4f75\u75c7\u7814\u7a76\u4f1a\u30012020.1(\u3064\u304f\u3070\uff09<\/li>\n<\/ol>\n\n\n\n

                            \u5e73\u621030\u5e74\u5ea6<\/h3>\n\n\n\n

                            \u3010\u8457\u66f8\u30fb\u7dcf\u8aac\u3011<\/p>\n\n\n\n

                              \n
                            1. \u5409\u5ddd\u88d5\u4e4b. \u5973\u3068\u7537\u306e\u30c7\u30a3\u30af\u30b7\u30e7\u30ca\u30ea\u30fc Human+.\uff08\u65e5\u672c\u7523\u79d1\u5a66\u4eba\u79d1\u5b66\u4f1a\u7de8\u8457\uff09. 18.\u601d\u6625\u671f\u306b\u53d7\u3051\u308b\u4e3b\u306a\u30ef\u30af\u30c1\u30f3. 38-39 \u9801\u30012018<\/li>\n<\/ol>\n\n\n\n

                              \u3010\u8ad6\u6587\u3011<\/p>\n\n\n\n

                                \n
                              1. Garland SM, Pitisuttithum P, Ngan HYS, Cho CH, Lee CY, Chen CA, Yang YC, Chu TY, TwuNF, Samakoses R, Takeuchi Y, Cheung TH, Kim SC, Huang LM, Kim BG, Kim YT, Kim KH, Song YS, Lalwani S, Kang JH, Sakamoto M, Ryu HS, Bhatla N, Yoshikawa H, Ellison MC, Han SR, Moeller E, Murata S, Ritter M, Sawata M, Shields C, Walia A, Perez G, Luxembourg A. Efficacy, immunogenicity, and safety of a 9-valent human papillomavirus vaccine: subgroup analysis of participants from Asian countries. J Infectious Diseases, 218(1):95-108, 2018<\/li>\n\n\n\n
                              2. Lachkar B, Minaguchi T, Akiyama A, Liu S, Zhang S, Xu C, Shikama A, Tasaka N, Sakurai M, Nakao S, Ochi H, Matsumoto K, Yoshikawa H, Satoh T. Prognostic significance of PIK3CA mutation in stage IIB to IVA cervical cancers treated by concurrent chemoradiotherapy with weekly cisplatin. Medicine (Baltimore). 97(31):e11392, 2018<\/li>\n\n\n\n
                              3. Onuki M, Matsumoto K, Tenjimbayashi Y, Tasaka N, Akiyama A, Sakurai M, Minaguchi T, Oki A, Satoh T, Yoshikawa H. Human papillomavirus genotype and prognosis of cervical cancer: favorable survival of patients with HPV16 positive tumors. Papillomavirus Research 6:41-45, 2018<\/li>\n\n\n\n
                              4. Inada K, Okoshi, Y, Cho-Isoda Y, Ishiguro S, Suzuki H, Oki A, Tamaki Y, Shimazui T, Saito H ,Hori M, Iijima T, Kojima H. Endogenous reference RNAs for microRNA quantitation in formalin-fixed, paraffin-embedded lymph node tissue. Scientific Reports. 8(1): 5918-27, 2018<\/li>\n\n\n\n
                              5. \u5c71\u53e3\u307e\u3069\u304b\uff0c\u9ad8\u91ce\u514b\u5df1\uff0c\u85e4\u679d\u85ab\uff0c\u677f\u57a3\u535a\u4e5f\uff0c\u6d25\u66f2\u7dbe\u5b50\uff0c\u9053\u4e0a\u5927\u96c4\uff0c\u7530\u5742\u66a2\u795f\uff0c\u79cb\u5c71\u6893\uff0c\u6c96\u660e\u5178\uff0c\u5409\u5ddd\u88d5\u4e4b: Nogitecan + bevacizumab \u7642\u6cd5\u306b\u3088\u308b\u8853\u524d\u5316\u5b66\u7642\u6cd5\u304c\u8457\u52b9\u3092\u793a\u3057\u305f\u30d7\u30e9\u30c1\u30ca\u88fd\u5264\u4e0d\u5fdc\u6027\u5375\u5de3\u764c IIIC \u671f\u306e 1 \u4f8b\uff0c\u8328\u57ce\u770c\u7acb\u75c5\u9662\u533b\u5b66\u96d1\u8a8c(35):1: 19-24, 2018<\/li>\n<\/ol>\n\n\n\n

                                \u3010\u5b66\u4f1a\u767a\u8868\u3011<\/p>\n\n\n\n

                                  \n
                                1. Onda T, Satoh T, Saito T, Kasamatsu T, Nakanishi T, Takehara K, Miyamoto K, Wakabayashi M, Okamoto A, Ushijima K, Kobayashi H, Kawana K, Yokota H, Takano M, Omatsu K, Watanabe Y, Yamamoto K, Yaegashi N, Kamura T, Yoshikawa H. Comparison of survival between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III\/IV ovarian, tubal and peritoneal cancers in phase III randomized trial: JCOG0602. 54th Annual Meeting of ASCO, 2018 (Chicago)<\/li>\n\n\n\n
                                2. \u6e29\u6cc9\u5ddd\u771f\u7531\u3001\u6069\u7530\u8cb4\u5fd7\uff64\u4e09\u6a4b \u6681\u3001\u677e\u5143 \u9686\u3001\u6c96 \u660e\u5178\u3001\u5fb3\u6c38\u79c0\u6a39\u3001\u6fa4\u5d0e \u9686\u3001\u9ad8\u91ce\u6d69\u90a6\u3001\u7530\u4ee3\u6d69\u5fb3\u3001\u5c71\u53e3 \u8061\u3001\u91ce\u6751\u5f18\u884c\uff64\u5bfa\u5c3e\u6cf0\u4e45\u3001\u83ca\u6c60 \u6717\uff64\u9e7f\u5cf6\u5927\u9756\u3001\u5ca1\u7559\u96c5\u592b\u3001\u6e21\u5229\u82f1\u9053\u3001\u99ac\u5834 \u9577\u3001\u516b\u6749\u654f\u6cbb\u3001\u52dd\u4fe3\u7bc4\u4e4b\u3001\u725b\u5d8b\u516c\u751f\uff64\u77f3\u5ddd\u5149\u4e5f\u3001\u516b\u91cd\u6a2b\u4f38\u751f. \u672c\u90a6\u306b\u304a\u3051\u308b\u9ad8\u9f62\u5a66\u4eba\u79d1\u60aa\u6027\u816b\u760d\u306b\u5bfe\u3059\u308b\u6cbb\u7642\u306e\u5b9f\u614b\u3092\u660e\u3089\u304b\u306b\u3059\u308b\u305f\u3081\u306e\u30a2\u30f3\u30b1\u30fc\u30c8\u8abf\u67fb. \u7b2c 70 \u56de\u65e5\u672c\u7523\u79d1\u5a66\u4eba\u79d1\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a\u30012018.5 (\u4ed9\u53f0)<\/li>\n\n\n\n
                                3. \u5712\u539f\u4e00\u6075\u3001\u79cb\u5c71\u9806\u5b50\u3001\u6c96 \u660e\u5178\u3001\u5b89\u7530\u6709\u7406\u3001\u658e\u85e4 \u8aa0. \u770b\u8b77\u5e2b\u304c\u884c\u3046\u5a66\u4eba\u79d1\u764c\u3092\u5bfe\u8c61\u3068\u3057\u305f\u907a\u4f1d\u6027\u816b\u760d\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u306e\u73fe\u72b6\u3068\u8ab2\u984c. \u7b2c 24 \u56de\u65e5\u672c\u5bb6\u65cf\u6027\u816b\u760d\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30012018.6 (\u795e\u6238)<\/li>\n\n\n\n
                                4. \u9ad8\u5c3e\u822a\u3001\u6c96\u660e\u5178\u3001\u6e21\u908a\u660e\u6075\u3001\u9234\u6728\u3042\u3059\u304b\u3001\u9053\u4e0a\u5927\u96c4\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u6f06\u5ddd\u90a6\uff64\u9ad8\u91ce\u514b\u5df1\u3001\u5409\u5ddd\u88d5\u4e4b. \u8840\u5c0f\u677f\u6e1b\u5c11\u9077\u5ef6\u306b\u3088\u308b T\uff23\u7642\u6cd5\u7d99\u7d9a\u56f0\u96e3\u306b\u5bfe\u3057\u3066\u813e\u52d5\u8108\u585e\u6813\u8853\u306b\u3088\u308a\u518d\u958b\u3057\u5f97\u305f\u5375\u5de3Highgrade serous carcinoma IIIc \u671f\u306e\u4e00\u4f8b. \u7b2c 135 \u56de\u95a2\u6771\u9023\u5408\u7523\u79d1\u5a66\u4eba\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30012018.6(\u6771 \u4eac)<\/li>\n\n\n\n
                                5. \u9ad8\u91ce\u514b\u5df1\u3001\u6e21\u908a\u660e\u6075\u3001\u9234\u6728\u3042\u3059\u304b\u3001\u9ad8\u5c3e \u822a\u3001\u9053\u4e0a\u5927\u96c4\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u6f06\u5ddd\u90a6\u3001\u6c96\u660e\u5178\u3001\u5409\u5ddd\u88d5\u4e4b. \u8179\u8154\u93e1\u7528\u30c8\u30ed\u30c3\u30ab\u30fc\u30d0\u30eb\u30d6\u7834\u640d\u306e 1 \u4f8b. \u7b2c 58 \u56de\u65e5\u672c\u7523\u79d1\u5a66\u4eba\u79d1\u5185\u8996\u93e1\u5b66\u4f1a\u30012018.8\uff08\u677e\u6c5f\uff09<\/li>\n\n\n\n
                                6. \u9ad8\u91ce\u514b\u5df1\u3001\u6e21\u908a\u660e\u6075\u3001\u9234\u6728\u3042\u3059\u304b\u3001\u9ad8\u5c3e\u822a\uff64\u9053\u4e0a\u5927\u96c4\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u6f06\u5ddd \u90a6\uff64\u6c96 \u660e\u5178\u3001\u5409\u5ddd\u88d5\u4e4b. \u8179\u8154\u93e1\u65bd\u884c\u6642\u306b IIIc \u671f\u3060\u3063\u305f BRCA2 \u5909\u7570\u967d\u6027\u5375\u7ba1\u764c\u306e\u4e00\u4f8b. \u7b2c 187 \u56de\u8328\u57ce\u7523\u79d1\u5a66\u4eba\u79d1\u5b66\u4f1a\u4f8b\u4f1a\u30012018.10 (\u6c34\u6238)<\/li>\n\n\n\n
                                7. \u77f3\u585a\u83dc\u6458\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u6e21\u908a\u660e\u6075\u3001\u9234\u6728\u3042\u3059\u304b\u3001\u9ad8\u5c3e\u822a\u3001\u9053\u4e0a\u5927\u96c4\u3001\u6f06\u5ddd\u90a6\uff64\u9ad8\u91ce\u514b\u5df1\u3001\u6c96\u660e\u5178\u3001\u5409\u5ddd\u88d5\u4e4b. \u9662\u5185\u52a9\u7523\uff08\u52a9\u7523\u30b1\u30a2\u4e2d\u5fc3\u306e\u598a\u5a20\uff65\u51fa\u7523\u652f\u63f4\u30b7\u30b9\u30c6\u30e0\uff09\u3067\u7ba1\u7406\u3055\u308c\u3066\u3044\u305f\u4f4e\u30ea\u30b9\u30af\u598a\u5a66\u306b\u767a\u75c7\u3057\u305f\u5206\u5a29\u5b50\u7647\u306e\u4e00\u4f8b. \u7b2c 187 \u56de\u8328\u57ce\u7523\u79d1\u5a66\u4eba\u79d1\u5b66\u4f1a\u4f8b\u4f1a\u30012018.10 (\u6c34\u6238)<\/li>\n\n\n\n
                                8. \u6d77\u8001\u6fa4\u88d5\u9999\u3001\u5409\u7530\u4e43\u5b50\u3001\u7530\u5c71\u9ebb\u8863\u5b50\u3001\u4e2d\u5ead\u5bcc\u58eb\u5b50\u3001\u67cf\u5f69\u7e54\uff64\u79cb\u5c71\u9806\u5b50\u3001\u6c96\u660e\u5178. \u5b50\u5bae\u4f53\u764c\u306e\u7d42\u672b\u671f\u60a3\u8005\u306b\u304a\u3051\u308b\u610f\u5fd7\u6c7a\u5b9a\u30fb\u9000\u9662\u652f\u63f4\u306b\u5411\u3051\u305f\u4ed6\u8077\u7a2e\u9023\u643a. \u7b2c 7 \u56de\u5a66\u4eba\u79d1\u816b\u760d\u306e\u7de9\u548c\u533b\u7642\u3092\u8003\u3048\u308b\u4f1a\u5b66\u8853\u96c6\u4f1a\u30012018.11\uff08\u963f\u898b\uff09<\/li>\n\n\n\n
                                9. \u6e21\u908a\u660e\u6075\u3001\u9053\u4e0a\u5927\u96c4\u3001\u9234\u6728\u3042\u3059\u304b\uff64\u9ad8\u5c3e\u822a\uff64\u7389\u4e95\u306f\u308b\u306a\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u6f06\u5ddd\u90a6\uff64\u9ad8\u91ce\u514b\u5df1\u3001\u6c96\u660e\u5178\u3001\u5409\u5ddd\u88d5\u4e4b. Gemcitabine \u306b\u3088\u308b\u9593\u8cea\u6027\u80ba\u708e\u3078\u306e\u6cbb\u7642\u304c\u594f\u529f\u3057\u305f\u518d\u767a\u5375\u5de3\u764c\u306e\u4e00\u4f8b. 136 \u56de\u95a2\u6771\u9023\u5408\u7523\u79d1\u5a66\u4eba\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30012018.11 (\u6771\u4eac)<\/li>\n\n\n\n
                                10. \u9234\u6728\u3042\u3059\u304b\uff64\u6c96\u660e\u5178\u3001\u6e21\u908a\u660e\u6075\u3001\u9ad8\u5c3e\u822a\uff64\u7389\u4e95\u306f\u308b\u306a\uff64\u9053\u4e0a\u5927\u96c4\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u6f06\u5ddd\u90a6\uff64\u9ad8\u91ce\u514b\u5df1\u3001\u5409\u5ddd\u88d5\u4e4b. \u9759\u8108\u8840\u6813\u585e\u6813\u75c7\u3092\u5408\u4f75\u3057\u305f\u5a66\u4eba\u79d1\u60aa\u6027\u816b\u760d\u60a3\u8005\u306b\u5bfe\u3059\u308b\u76f4\u63a5\u7684\u7d4c\u53e3\u6297\u51dd\u56fa\u85ac\u306e\u4f7f\u7528\u7d4c\u9a13. \u7b2c 136 \u56de\u95a2\u6771\u9023\u5408\u7523\u79d1\u5a66\u4eba\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30012018.11 (\u6771\u4eac)<\/li>\n<\/ol>\n\n\n\n

                                  \u5e73\u621029\u5e74\u5ea6<\/h3>\n\n\n\n

                                  \u3010\u8457\u66f8\u30fb\u7dcf\u8aac\u3011<\/p>\n\n\n\n

                                    \n
                                  1. \u5409\u5ddd\u88d5\u4e4b. \u7dcf\u8aac\uff1aHPV \u30ef\u30af\u30c1\u30f3\u63a5\u7a2e\u4e8b\u696d\u306b\u3064\u3044\u3066\u2212\u305d\u306e\u6cbf\u9769\u3068\u6700\u8fd1\u306e\u52d5\u5411\u2212. \u764c\u3068\u5316\u5b66\u7642\u6cd544(9):713-716, 2017 2. \u5409\u5ddd\u88d5\u4e4b. \u7279\u96c6 DPC II \u7fa4\u75c5\u9662\u306e\u7d4c\u55b6\u6226\u7565. \u75c5\u9662\u7d4c\u55b6\u6226\u7565\u3068\u30df\u30c3\u30b7\u30e7\u30f3\u3001\u30d3\u30b8\u30e7\u30f3 \u75c5\u9662\u7d4c\u55b6 MASTER 63:9-13, 2018<\/li>\n<\/ol>\n\n\n\n

                                    \u3010\u8ad6\u6587\u3011<\/p>\n\n\n\n

                                      \n
                                    1. \u677f\u57a3\u535a\u4e5f\u3001\u9ad8\u91ce\u514b\u5df1\u3001\u7389\u4e95\u306f\u308b\u306a\u3001\u9053\u4e0a\u5927\u96c4\u3001\u7530\u5742\u66a2\u5d07\u3001\u79cb\u5c71 \u6893\u3001\u6c96 \u660e\u5178\u3001\u5409\u5ddd\u88d5\u4e4b. \u8853\u524d\u7cbe\u67fb\u3067\u5375\u5de3 \u56ca\u80de\u3068\u306e\u9451\u5225\u3092\u8981\u3057\u305f\u524d\u4ed9\u9aa8\u9ac4\u819c\u7624\u306e 1 \u4f8b, \u95a2\u6771\u9023\u5408\u7523\u79d1\u5a66\u4eba\u79d1\u5b66\u4f1a\u8a8c, 54(1)\uff1a69-72, 2017<\/li>\n\n\n\n
                                    2. Matsumoto K, Yaegashi N, Iwata T, Yamamoto K, Nagashima M, Saito T, Ushijima K, Takahashi F, Noda K, Yoshikawa H. Early impact of the Japanese immunization program implemented before the HPV vaccination crisis. Int J Cancer, 141(8):1704-1706, 2017<\/li>\n\n\n\n
                                    3. Liu S, Minaguchi T, Lachkar B, Zhang S, Xu C, Tenjimbayashi Y, Shikama A, Tasaka N, Akiyama A, Sakurai M, Nakao S, Ochi H, Onuki M, Matsumoto K, Yoshikawa H, Satoh T. Separate analysis of human papillomavirus E6 and E7 messenger RNAs to predict cervical neoplasia progression. PLoS One. 21;13(2):e0193061, 2018.<\/li>\n<\/ol>\n\n\n\n

                                      \u3010\u5b66\u4f1a\u5831\u544a\u3011<\/p>\n\n\n\n

                                        \n
                                      1. \u6c96 \u660e\u5178. \u5b50\u5bae\u9838\u304c\u3093\u691c\u8a3a\u5468\u8fba\u306e\u6700\u8fd1\u306e\u8a71\u984c. \u5b50\u5bae\u9838\u304c\u3093\u691c\u8a3a\u5f93\u4e8b\u8005\u8b1b\u7fd2\u4f1a\uff0e2017.3\uff08\u3064\u304f\u3070\uff09<\/li>\n\n\n\n
                                      2. \u85e4\u679d \u85ab\u3001\u6c96 \u660e\u5178\u3001\u5c71\u53e3\u307e\u3069\u304b\u3001\u6d25\u66f2\u7dbe\u5b50\u3001\u7389\u4e95\u306f\u308b\u306a\u3001\u9053\u4e0a\u5927\u96c4\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u9ad8\u91ce\u514b\u5df1\u3001\u5409\u5ddd\u88d5\u4e4b. \u5b50\u5bae\u9838\u90e8\u5c0f\u7d30\u80de\u764c\u306b\u4f75\u767a\u3057\u305f SIADH \u306b\u3088\u308b\u4f4e Na \u8840\u75c7\u306e\u7ba1\u7406\u306b\u96e3\u6e0b\u3057\u305f\u4e00\u4f8b\uff0e\u7b2c184 \u56de\u8328\u57ce\u7523\u79d1\u5a66\u4eba\u79d1 \u5b66\u4f1a\u4f8b\u4f1a\uff0e2017.6\uff08\u6c34\u6238\uff09<\/li>\n\n\n\n
                                      3. \u68ee \u60a0\u6a39\u3001\u6c96 \u660e\u5178\u3001\u5c0f\u5cf6\u4f51\u57fa\u3001\u85e4\u679d \u85ab\u3001\u6d25\u66f2\u7dbe\u5b50\u3001\u9053\u4e0a\u5927\u96c4\u3001\u7389\u4e95\u306f\u308b\u306a\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u9ad8\u91ce\u514b\u5df1\u3001\u5409 \u5ddd\u88d5\u4e4b. \u6210\u4eba\u5f8c\u306b\u8a3a\u65ad\u3055\u308c\u3001informed Consent(IC)\u306b\u82e6\u616e\u3057\u305f Swyer \u75c7\u5019\u7fa4\u306e\u4e00\u4f8b.\u7b2c 184 \u56de\u8328\u57ce\u7523\u79d1 \u5a66\u4eba\u79d1\u5b66\u4f1a\u4f8b\u4f1a\uff0e2017.6\uff08\u6c34\u6238\uff09<\/li>\n\n\n\n
                                      4. \u6c96 \u660e\u5178. \u5b50\u5bae\u5185\u819c\u75c7\uff65\u5b50\u5bae\u817a\u7b4b\u75c7\u306e\u6700\u8fd1\u306e\u8a71\u984c. \u7b20\u9593\u5e02\u85ac\u5264\u5e2b\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a\uff0e2017.6<\/li>\n\n\n\n
                                      5. \u5ca1\u5d0e\u6709\u9999\u3001\u4e95\u4e0a\u4e45\u7f8e\u5b50\u3001\u9752\u6728\u5343\u6d25\u3001\u6e21\u908a\u4e4b\u592b\u3001\u7530\u5742\u66a2\u5d07\u3001\u65b0\u4e95\u3086\u3046\u5b50\u3001\u6c96 \u660e\u5178\u3001\u5ca1\u672c \u4e00\u3001\u91cd\u5149\u8c9e\u5f66\u3001\u4f50 \u85e4 \u8c4a\u5b9f. \u9589\u7d4c\u524d\u8840\u4e2d\u30a8\u30ea\u30b9\u30ed\u30dd\u30a8\u30c1\u30f3\u5024\u306f\u5b50\u5bae\u7b4b\u816b\u8d64\u8840\u7403\u5897\u591a\u75c7\u306e\u4e88\u6e2c\u306b\u6709\u7528\u304b. \u7b2c133 \u56de \u95a2\u6771\u9023\u5408\u7523 \u79d1\u5a66\u4eba\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2017. 6\uff08\u6771\u4eac\uff09<\/li>\n\n\n\n
                                      6. \u9ad8\u91ce\u514b\u5df1\u3001\u5c0f\u5cf6\u7950\u57fa\u3001\u68ee \u60a0\u6a39\u3001\u7389\u4e95\u306f\u308b\u306a\u3001\u9053\u4e0a\u96c4\u5927\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u6f06\u5ddd \u90a6\u3001\u6c96 \u660e\u5178\u3001\u5409\u5ddd\u88d5\u4e4b. \u5f53 \u9662\u306b\u304a\u3051\u308b\u8179\u8154\u93e1\u4e0b\u5b50\u5bae\u5168\u6458\u306e\u5c0e\u5165\u7d4c\u9a13. \u7b2c 185 \u56de\u8328\u57ce\u7523\u79d1\u5a66\u4eba\u79d1\u5b66\u4f1a\u4f8b\u4f1a\uff0e2017.9\uff08\u6c34\u6238\uff09<\/li>\n\n\n\n
                                      7. \u9f4b\u85e4 \u8aa0\u3001\u9d28\u7530\u77e5\u535a\u3001\u6c96 \u660e\u5178\u3001\u4e2d\u7530\u5f69\u9999\u3001\u7a32\u5ddd\u76f4\u6d69\u3001\u5c0f\u5cf6\u4f51\u57fa\u3001\u9ad8\u5c3e \u822a\u3001\u7389\u4e95\u306f\u308b\u306a\u3001\u9053\u4e0a\u5927\u96c4\u3001\u5b89\u90e8\u52a0 \u5948\u5b50\u3001\u6f06\u5ddd \u90a6\u3001\u9ad8\u91ce\u514b\u5df1. \u770c\u7acb\u4e2d\u592e\u75c5\u9662\u5206\u5a29\u518d\u958b\u5f8c\u306e\u5206\u5a29\u72b6\u6cc1\u306b\u3064\u3044\u3066. \u7b2c 116 \u56de\u8328\u57ce\u5c0f\u5150\u79d1\u5b66\u4f1a\uff0e2017.11<\/li>\n\n\n\n
                                      8. \u5c0f\u5cf6\u4f51\u57fa\u3001\u9053\u4e0a\u5927\u96c4\u3001\u68ee \u60a0\u6a39\u3001\u7389\u4e95\u306f\u308b\u306a\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u6f06\u5ddd \u90a6\u3001\u9ad8\u91ce\u514b\u5df1\u3001\u6c96 \u660e\u5178\u3001\u5409\u5ddd\u88d5\u4e4b. \u5375 \u5de3\u985e\u5185\u819c\u817a\u764c\u306b\u540c\u6642\u767a\u751f\u3057\u305f\u5b50\u5bae\u5185\u819c\u75c7\u7531\u6765\u306e\u76f4\u8178\u764c\u306e 1 \u4f8b. \u7b2c 134 \u56de\u95a2\u6771\u9023\u5408\u7523\u79d1\u5a66\u4eba\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e 2017.12\uff08\u5b87\u90fd\u5bae\uff09<\/li>\n\n\n\n
                                      9. Liu S, Minaguchi T, Lachkar B, Tenjimbayashi Y, Shikama A, Tasaka N, Akiyama A, Sakurai M, Nakao S, Ochi H, Satoh T, Yoshikawa H. Analysis of human papillomavirus oncogene E6\/E7 spliced transcripts in liquid-based cytology samples from patients with cervical neoplastic diseases. SGO 48th Annual Meeting on Women’s Cancer, 2017<\/li>\n\n\n\n
                                      10. Mikami M, Shida M, Shibata T, Kigawa J, Katabuchi H, Aoki D, Yoshikawa H, Yaegashi N. Implementation and quality assurance of training institutions for gynecologic oncologists in Japan. SGO 48th Annual Meeting on Women’s Cancer, 2017.<\/li>\n\n\n\n
                                      11. Liu S, Minaguchi T, Lachkar B, Tenjimbayashi Y, Shikama A, Tasaka N, Akiyama A, Sakurai M, Nakao S, Ochi H, Satoh T, Yoshikawa H. Analysis of human papillomavirus oncogene E6\/E7 spliced transcripts in liquid-based cytology samples from patients with cervical neoplastic diseases. 69th Annual Congress of the Japan Society of Obstetrics and Gynecology. 2017 (Hiroshima).<\/li>\n\n\n\n
                                      12. Onuki M, Matsumoto K, Tenjinbayashi Y, Nakao S, Sakurai M, Ochi H, Minaguchi T, Yoshikawa H, Satoh T. The impact of HPV genotypes in prognosis of advanced cervical cancer. 69th Annual Congress of the Japan Society of Obstetrics and Gynecology. 2017 (Hiroshima).<\/li>\n<\/ol>\n\n\n\n

                                        \u3010\u8b1b\u6f14\u3011<\/p>\n\n\n\n

                                          \n
                                        1. \u5409\u5ddd\u88d5\u4e4b. HPV \u30ef\u30af\u30c1\u30f3\u306e\u80cc\u666f\u3068\u5fc5\u8981\u6027. \u5b50\u5bae\u304c\u3093\u691c\u8a3a\u5f93\u4e8b\u8005\u8b1b\u7fd2\u4f1a. 2017.12\uff08\u6c34\u6238\u5e02\uff09<\/li>\n<\/ol>\n\n\n\n

                                          \u5e73\u621028\u5e74\u5ea6<\/h3>\n\n\n\n

                                          \u3010\u8457\u66f8\u3011<\/p>\n\n\n\n

                                            \n
                                          1. \u9ad8\u91ce\u514b\u5df1\u3001\u5409\u5ddd\u88d5\u4e4b \u5358\u7d14\u5b50\u5bae\u5168\u6458\u8853\uff3b2\uff3d\u3000\u8179\u5f0f\u5358\u7d14\u5b50\u5bae\u5168\u6458\u8853\uff082\uff09 \u7523\u5a66\u4eba\u79d1\u624b\u8853\u30b9\u30bf\u30f3\u30c0\u30fc\u30c9\u3000\u6539\u8a02\u7b2c2\u7248\u3001\u65e5\u672c\u7523\u5a66\u4eba\u79d1\u624b\u8853\u5b66\u4f1a\u7de8 \uff5083-91\u3001\u30e1\u30b8\u30ab\u30eb\u30d3\u30e5\u30fc\u793e\u30012017\/3\/31<\/li>\n<\/ol>\n\n\n\n

                                            \u3010\u8ad6\u6587\u3011<\/p>\n\n\n\n

                                              \n
                                            1. \u6c96\u660e\u5178.\u5b50\u5bae\u9838\u304c\u3093\u3068HPV -\u4e88\u9632\u3068\u6cbb\u7642\u306e\u6700\u8fd1\u306e\u8a71\u984c\u30fc\u3000\u9577\u91ce\u770c\u6bcd\u5b50\u885b\u751f\u5b66\u4f1a\u8a8c\uff11\uff18\u5dfb\uff11\u53f7: 1-4: 2016<\/li>\n\n\n\n
                                            2. Onuki M, Matsumoto K, Sakurai M, Ochi H, Minaguchi T, Satoh T, Yoshikawa H. Post-treatment HPV testing for residual or recurrent high-grade cervical intraepithelial neoplasia: a pooled analysis. J Gynecol Oncol, 27(1):e3., 2016<\/li>\n\n\n\n
                                            3. Shikama, A, Minaguchi, T , Matsumoto, K, Akiyama-Abe, A, Nakamura, Y , Michikami, H , Nakao, S,; Sakurai, M , Ochi, H , Onuki, M , Satoh, T , Oki, A , Yoshikawa, H Clinicopathologic implications of DNA mismatch repair status in endometrial carcinomas. Gynecol Oncol 140(2): 226-233, 2016<\/em><\/li>\n\n\n\n
                                            4. Tanaka YO, Okada S, Satoh T, Matsumoto K, Saida T, Minami M, Yoshikawa H.\u3000 Uterine cervical cancer volumetry using T2- and diffusion-weighted MR images in patients treated by primary surgery and neoadjuvant chemotherapy. Acta Radiol. 57(3):378-383, 2016<\/li>\n\n\n\n
                                            5. Saida T, Tanaka YO, Matsumoto K, Satoh T, Yoshikawa H, Minami M. Revised FIGO staging system for cancer of the ovary, fallopian tube, and peritoneum: important implication for radiologists. Jpn J Radiol,<\/li>\n\n\n\n
                                            6. Ohara R, Obata-Yasuoka M, Abe K, Yagi H, Hamada H, Yoshikawa H. Effect of hyperemesis gravidarum on gestational diabetes mellitus screening. Int J Gynaecol Obstet. 132(2):156-158, 2016.<\/li>\n\n\n\n
                                            7. Tanaka, YO, Okada, S , Satoh, T, Matsumoto, K, Oki, A , Saida, T , Yoshikawa, H , Minami, M\u3000Differentiation of epithelial ovarian cancer subtypes by use of imaging and clinical data: a detailed analysis. Cancer Imaging 10(3): 2016<\/li>\n\n\n\n
                                            8. Tanaka YO, Okada S, Sakata A, Saida T, Nagai M, Yoshikawa H, Noguchi M, Minami M.\u3000 A metastatic ovarian cancer mimicking pregnancy luteoma found during puerperium. Magn Reson Med Sci, 15(2):149-150, 2016<\/li>\n\n\n\n
                                            9. Minaguchi, T,Satoh, T, Matsumoto, K ,Sakurai, M ,Ochi, H, Onuki, M, Oki, A , Yoshikawa, H\u3000Proposal for selection criteria of secondary cytoreductive surgery in recurrent epithelial ovarian, tubal, and peritoneal cancersInt J Clin Oncol 21(3): 573-579, 2016.<\/li>\n\n\n\n
                                            10. Ebina Y, Katabuchi H, Mikami M, Nagase S, Yaegashi N, Udagawa Y, Kato H, Kubushiro K, Takamatsu K, Ino K, Yoshikawa H.\u3000  Japan Society of Gynecologic Oncology guidelines 2013 for the treatment of uterine body neoplasms. Int J Clin Oncol. 21(3):419-434, 2016<\/li>\n\n\n\n
                                            11. Iguchi-Manaka A, Okumura G, Kojima H, Cho Y, Hirochika R, Bando H, Sato T, Yoshikawa H, Hara H, Shibuya A, Shibuya K. Increased Soluble CD155 in the Serum of Cancer Patients. PLoS One 11(4):e0152982, 2016.<\/li>\n\n\n\n
                                            12. Onda T, Satoh T, Saito T, Kasamatsu T, Nakanishi T, Nakamura K, Wakabayashi  M, Takehara K, Saito M, Ushijima K, Kobayashi H, Kawana K, Yokota H, Takano M, Takeshima N, Watanabe Y, Yaegashi N, Konishi I, Kamura T, Yoshikawa H. Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III\/IV ovarian, tubal, and peritoneal cancers in a phase III randomized trial: Japan Clinical Oncology Group Study JCOG0602. Eur J Cancer, Sep 64:22-31, 2016<\/li>\n\n\n\n
                                            13. Abe K, Hamada H, Fujiki Y, Iiba M, Tenjinnbayashi Y, Yoshikawa H.\u3000 Radiological diagnosis of gas gangrene in a fetus at term. Taiwan J Obstet Gynecol. 55(4):582-584, 2016<\/li>\n\n\n\n
                                            14. Satoh T, Yoshikawa H. Fertility-sparing surgery for early stage epithelial ovarian cancer. Jpn J Clin Oncol. 46(8):703-10, 2016<\/li>\n\n\n\n
                                            15. Nishio, S, Kitagawa, R, Shibata, T, Yoshikawa, H, Konishi, I, Ushijima, K, Kamura, T. Prognostic factors from a randomized phase III trial of paclitaxel and carboplatin versus paclitaxel and cisplatin in metastatic or recurrent cervical cancer: Japan Clinical Oncology Group (JCOG) trial: JCOG0505 Cancer Chemotherapy and Pharmacology, 78(4):785-790, 2016<\/li>\n\n\n\n
                                            16. Sakurai M, Matsumoto K, Gosho M, Sakata A, Hosokawa Y, Tenjimbayashi Y, Katoh T, Shikama A, Komiya H, Michikami H, Tasaka N, Akiyama-Abe A, Nakao S, Ochi H, Onuki M, Minaguchi T, Yoshikawa H, Satoh T.\u3000 Expression of Tissue Factor in Epithelial Ovarian Carcinoma Is Involved in the Development of Venous Thromboembolism. Int J Gynecol Cancer, 27(1):37-43, 2017<\/li>\n\n\n\n
                                            17. Kawasaki A, Okamoto H, Wada A, Ainoya Y, Kita N, Maeyama T, Edamoto N, Nishiyama H, Tsukamoto S, Joraku A, Waku N, Yoshikawa H. A case of primary ciliary dyskinesia treated with testicular spermatozoa: case report and a review of the literature. Reprod Med Biol,<\/li>\n\n\n\n
                                            18. \u9ad8\u91ce\u514b\u5df1\u3001\u5409\u5ddd\u88d5\u4e4b\u3000\u5a66\u4eba\u79d1\u60aa\u6027\u816b\u760d\u306e\u8a3a\u65ad\u3068\u6cbb\u7642\u3000\u5b50\u5bae\u9838\u764c\u3000\u533b\u5b66\u3068\u85ac\u5b66\u3000\u7b2c73\u5dfb\u7b2c4\u53f7\u3001\uff50379-384\u30012016<\/li>\n\n\n\n
                                            19. Komiyama S, Katabuchi H, Mikami M, Nagase S, Okamoto A, Ito K, Morishige K, Suzuki N, Kaneuchi M, Yaegashi N, Udagawa Y, Yoshikawa H. Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of ovarian cancer including primary peritoneal cancer and fallopian tube cancer. Int J Clin Oncol. 21(3):435-446, 2016<\/li>\n\n\n\n
                                            20. Sugiyama T, Okamoto A, Enomoto T, Hamano T, Aotani E, Terao Y, Suzuki N, Mikami M, Yaegashi N, Kato K, Yoshikawa H, Yokoyama Y, Tanabe H, Nishino K, Nomura H, Kim JW, Kim BG, Pignata S, Alexandre J, Green J, Isonishi S, Terauchi F, Fujiwara K, Aoki D. Randomized phase III Trial of irinotecan plus cisplatin compared with paclitaxel plus carboplatin as first-line chemotherapy for ovarian clear cell carcinoma: JGOG3017\/GCIG Trial. J Clin Oncol Aug 20;34(24):2881-2887, 2016<\/li>\n<\/ol>\n\n\n\n

                                              \u3010\u5b66\u4f1a\u5831\u544a\u3011<\/p>\n\n\n\n

                                                \n
                                              1. \u79cb\u5c71 \u6893\u3001\u677f\u57a3 \u535a\u4e5f\u3001\u7389\u4e95 \u306f\u308b\u306a\u3001\u9053\u4e0a\u5927\u96c4\u3001\u7530\u5742\u66a2\u795f\u3001\u9ad8\u91ce\u514b\u5df1\u3001\u6c96 \u660e\u5178\u3000\u9032\u884c\u5375\u5de3\u764c\u6cbb\u7642\u4e2d\u306e\u96e3\u6cbb\u6027\u8179\u6c34\u306b\u5bfe\u3057\u30ea\u30f3\u30d1\u7ba1\u9020\u5f71\u306b\u3066\u8179\u6c34\u30b3\u30f3\u30c8\u30ed\u30fc\u30eb\u3057\u3048\u305f\u4e00\u4f8b\u3000\u7b2c68\u56de\u65e5\u672c\u7523\u79d1\u5a66\u4eba\u79d1\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a(\u6771\u4eac)2016.4<\/li>\n\n\n\n
                                              2. Shikama Ayumi; Minaguchi Takeo; Matsumoto Koji; Akiyama Azusa; Hiroyuki  Ochi; Akinori Ok; Toyomi Satoh Clinical impact of DNA mismatch  repair status in endometrial carcinoma. \u7b2c68\u56de\u65e5\u672c\u7523\u79d1\u5a66\u4eba\u79d1\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a(\u6771\u4eac)2016.4<\/li>\n\n\n\n
                                              3. \u85e4\u679d \u85ab\u3001\u79cb\u5c71 \u6893\u3001\u5c71\u53e3\u307e\u3069\u304b\u3001\u6d25\u66f2\u7dbe\u5b50\u3001\u7389\u4e95\u306f\u308b\u306a\u3001\u9053\u4e0a\u5927\u96c4\u3001\u9ad8\u91ce\u514b\u5df1\u3001\u6c96 \u660e\u5178\u3001\u5409\u5ddd\u88d5\u4e4b. \u5185\u8996\u93e1\u624b\u8853\u7528\u30eb\u30fc\u30d7\u5f0f\u7d50\u7d2e\u5668\u5177\u3092\u7528\u3044\u305f\u7b4b\u816b\u68df\u5b50\u5bae\u5185\u304b\u3089\u8131\u51fa\u3057\u305f\u4e3b\u6d41\u306e\u7ba1\u7406\u6cd5 \u7b2c182\u56de\u8328\u57ce\u7523\u79d1\u5a66\u4eba\u79d1\u5b66\u4f1a\u4f8b\u4f1a(\u3064\u304f\u3070) 2016.6.11<\/li>\n\n\n\n
                                              4. \u5c71\u53e3\u307e\u3069\u304b\u3001\u9053\u4e0a\u5927\u96c4\u3001\u85e4\u679d \u85ab\u3001\u677f\u57a3\u535a\u4e5f\u3001\u6d25\u66f2\u7dbe\u5b50\u3001\u7389\u4e95\u306f\u308b\u306a\u3001\u7530\u5742\u66a2\u795f\u3001\u79cb\u5c71 \u6893\u3001\u9ad8\u91ce\u514b\u5df3\u3001\u6c96 \u660e\u5178\u3001\u5409\u5ddd\u88d5\u4e4b. \u539f\u767a\u5de3\u540c\u5b9a\u306b\u96e3\u6e0b\u3057\u305f\u5375\u5de3\u2022\u5927\u8178\u816b\u760d\u5408\u4f75\u306e\uff14\u75c7\u4f8b\u3000-cytokeratin7\/20\u767a\u73feprofile\u306e\u6709\u7528\u6027\u3068pitfall-\u7b2c131\u56de\u95a2\u6771\u9023\u5408\u7523\u79d1\u5a66\u4eba\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff08\u6771\u4eac\uff092016.6.18<\/li>\n\n\n\n
                                              5. \u6c96 \u660e\u5178 \u5b50\u5bae\u5185\u819c\u75c7\u2022\u5b50\u5bae\u817a\u7b4b\u75c7\u306e\u6700\u8fd1\u306e\u77e5\u898b\u8328\u57ce\u770c\u7523\u5a66\u4eba\u79d1\u533b\u4f1a\u770c\u5317\u652f\u90e8\u5b66\u8853\u8b1b\u6f14\u4f1a\uff08\u65e5\u7acb\uff092016.7.14<\/li>\n\n\n\n
                                              6. \u6d25\u66f2\u7dbe\u5b50\u3001\u9ad8\u91ce\u514b\u5df1\u3001\u85e4\u679d \u85ab\u3001\u5c71\u53e3\u307e\u3069\u304b\u3001\u7389\u4e95\u306f\u308b\u306a\u3001\u9053\u4e0a\u5927\u96c4\uff64\u79cb\u5c71 \u6893\u3001\u5b89\u90e8\u52a0\u5948\u5b50\u3001\u6c96 \u660e\u5178\u3001\u5409\u5ddd\u88d5\u4e4b, \u5f53\u9662\u3067\u7ba1\u7406\u3057\u305f\u5e1d\u738b\u5207\u958b\u7622\u75d5\u90e8\u598a\u5a20\u306e2\u4f8b\u3000\u7b2c132\u56de\u95a2\u6771\u9023\u5408\u7523\u79d1\u5a66\u4eba\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a(\u6771\u4eac)2016.10.15<\/li>\n\n\n\n
                                              7. \u5ca1\u5d0e\u6709\u9999\u3001\u9752\u6728\u5343\u6d25\u3001\u4e95\u4e0a\u4e45\u7f8e\u5b50)<\/sup>\u3001\u6e21\u908a\u4e4b\u592b\u3001\u5c0f\u6c60\u6570\u4e0e\u3001\u6c96 \u660e\u5178 \u5b50\u5bae\u9838\u90e8\u5de8\u5927\u816b\u7624\u3092\u5448\u3057\u305f\u5e1d\u738b\u5207\u958b\u5275\u90e8\u5b50\u5bae\u5185\u819c\u75c7\u306e\uff11\u4f8b \u7b2c132\u56de\u95a2\u6771\u9023\u5408\u7523\u79d1\u5a66\u4eba\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a(\u6771\u4eac)2016.10.16<\/li>\n\n\n\n
                                              8. Yuri Tenjimbayashi, Koji Matsumoto, Mamiko Onuki, Sari Nakao, Manabu Sakurai, Hiroyuki Ochi, Takeo Minaguchi, Toyomi Satoh, Akinori Oki, Hajime Tsunoda, Hiroyuki Yoshikawa\uff0ePara-aortic lymphadenectomy for endometrial cancer: proposal for patient selection\uff0e\u3000The 16th Biennial Meeting of the International Gynecologic Cancer Society.Oct29-31(Lisbon,Portugal)<\/li>\n<\/ol>\n\n\n\n

                                                \u3010\u4e3b\u50ac\u7814\u7a76\u4f1a\u7b49\u3011<\/p>\n\n\n\n

                                                  \n
                                                1. \u533b\u7642\u5f93\u4e8b\u8005\u306e\u5c02\u9580\u6027\u3092\u767a\u63ee\u3059\u308b\u30c1\u30fc\u30e0\u533b\u7642\u7814\u4fee\u4f1a\u300c\u85ac\u7269\u7642\u6cd5\u306b\u304a\u3051\u308b\u30c1\u30fc\u30e0\u533b\u7642\u300d\u8328\u57ce\u770c\u304c\u3093\u8a3a\u7642\u62e0\u70b9\u75c5\u9662\u6a5f\u80fd\u5f37\u5316\u4e8b\u696d\u3000<\/li>\n\n\n\n
                                                2. \u5e02\u6c11\u516c\u958b\u30bb\u30df\u30ca\u30fc\u3000\u5973\u6027\u7279\u6709\u306e\u304c\u3093\uff5e\u4e73\u304c\u3093\uff0c\u5b50\u5bae\u30fb\u5375\u5de3\u306e\u304c\u3093\u3000(\u3064\u304f\u3070\u5e02)<\/li>\n\n\n\n
                                                3. \u5e02\u6c11\u516c\u958b\u30bb\u30df\u30ca\u30fc\u3000\u5973\u6027\u7279\u6709\u306e\u304c\u3093\uff5e\u4e73\u304c\u3093\uff0c\u5b50\u5bae\u30fb\u5375\u5de3\u306e\u304c\u3093\u3000(\u6c34\u6238\u5e02)<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

                                                  \u5e73\u621028\u5e74\u5ea6\uff5e\u4ee4\u548c6\u5e74\u5ea6 \u4ee4\u548c6\u5e74\u5ea6 \u3010\u8ad6\u6587\u3011 \u3010\u5b66\u4f1a\u767a\u8868\u3011 \u4ee4\u548c5\u5e74\u5ea6 \u3010\u8ad6\u6587\u3011 \u4ee4\u548c4\u5e74\u5ea6 \u3010\u8ad6\u6587\u3011 \u3010\u5b66\u4f1a\u5831\u544a\u3011 \u4ee4\u548c3\u5e74\u5ea6 \u3010\u8ad6\u6587\u3011 \u3010\u5b66\u4f1a\u5831\u544a\u3011 \u4ee4\u548c2\u5e74\u5ea6 \u3010\u8ad6\u6587\u3011 \u3010\u5b66\u4f1a\u5831\u544a\u3011 \u3010\u8b1b\u6f14\u3011 \u4ee4\u548c\u5143\u5e74\u5ea6 \u3010\u8ad6\u6587 […]<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":799,"menu_order":1,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":"","vk-ltc-link":"","vk-ltc-target":"0"},"class_list":["post-16894","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/wp-json\/wp\/v2\/pages\/16894","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/wp-json\/wp\/v2\/comments?post=16894"}],"version-history":[{"count":3,"href":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/wp-json\/wp\/v2\/pages\/16894\/revisions"}],"predecessor-version":[{"id":25106,"href":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/wp-json\/wp\/v2\/pages\/16894\/revisions\/25106"}],"up":[{"embeddable":true,"href":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/wp-json\/wp\/v2\/pages\/799"}],"wp:attachment":[{"href":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/wp-json\/wp\/v2\/media?parent=16894"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}